SARS-CoV-2-Queries

compareViruses.rq

Broncode voorbeelden: curl

SPARQL

SELECT DISTINCT ?virus ?virusLabel ?work ?workLabel WITH {
  SELECT DISTINCT ?virus ?virus2 ?work WHERE {
    VALUES ?virus {
      wd:Q82069695 # SARS-CoV-2
      wd:Q16983360 # HKU1
      wd:Q16991954 # OC43
      wd:Q8351095  # NL63 
      wd:Q16983356 # 229E 
      wd:Q4902157  # MERS-CoV
      wd:Q278567   # SARS-CoV
    }
    ?virus2 wdt:P171+ wd:Q57751738 .
    ?work wdt:P921 ?virus, ?virus2 .
    FILTER ( ?virus != ?virus2 )
  }
} AS %ARTICLES WHERE {
  INCLUDE %ARTICLES
  SERVICE wikibase:label { bd:serviceParam wikibase:language "nl,en". }
}
ORDER BY ?virusLabel ?virus ?workLabel ?work

uitvoeren of bewerken

Resultaten

virus work
Menselijk Coronavirus NL63 (edit) Detection of the human coronavirus 229E, HKU1, NL63, and OC43 between 2010 and 2013 in Yamagata, Japan (edit)
Menselijk Coronavirus NL63 (edit) Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients (edit)
Menselijk Coronavirus NL63 (edit) Inhibition of endoplasmic reticulum-resident glucosidases impairs severe acute respiratory syndrome coronavirus and human coronavirus NL63 spike protein-mediated entry by altering the glycan processing of angiotensin I-converting enzyme 2. (edit)
Menselijk Coronavirus NL63 (edit) SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells (edit)
Menselijk Coronavirus NL63 (edit) SARS-CoV, but not HCoV-NL63, utilizes cathepsins to infect cells: viral entry (edit)
Menselijk Coronavirus NL63 (edit) The S proteins of human coronavirus NL63 and severe acute respiratory syndrome coronavirus bind overlapping regions of ACE2. (edit)
Menselijk Coronavirus NL63 (edit) Attachment factor and receptor engagement of SARS coronavirus and human coronavirus NL63. (edit)
Menselijk Coronavirus NL63 (edit) Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal coronaviruses (edit)
Menselijk Coronavirus NL63 (edit) Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63. (edit)
Menselijk Coronavirus NL63 (edit) Human Coronaviruses HCoV-NL63 and HCoV-HKU1 in Hospitalized Children with Acute Respiratory Infections in Beijing, China (edit)
Menselijk Coronavirus NL63 (edit) Increased Incidence, Morbidity, and Mortality in Human Coronavirus NL63 Associated with ACE Inhibitor Therapy and Implication in SARS-CoV-2 (COVID-19) (edit)
Menselijk Coronavirus NL63 (edit) Message in a bottle: lessons learned from antagonism of STING signalling during RNA virus infection (edit)
Menselijk Coronavirus NL63 (edit) Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease (edit)
Menselijk Coronavirus NL63 (edit) Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506. (edit)
Menselijk Coronavirus NL63 (edit) The novel human coronaviruses NL63 and HKU1. (edit)
Menselijk Coronavirus NL63 (edit) [Development and comparison of real-time and conventional RT-PCR assay for detection of human coronavirus NL63 and HKU1]. (edit)
Menselijk coronavirus 229E (edit) A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets (edit)
Menselijk coronavirus 229E (edit) Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by severe acute respiratory syndrome coronavirus and human coronavirus 229E. (edit)
Menselijk coronavirus 229E (edit) Detection of the human coronavirus 229E, HKU1, NL63, and OC43 between 2010 and 2013 in Yamagata, Japan (edit)
Menselijk coronavirus 229E (edit) Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients (edit)
Menselijk coronavirus 229E (edit) ADP-ribose-1"-phosphatase activities of the human coronavirus 229E and SARS coronavirus X domains (edit)
Menselijk coronavirus 229E (edit) Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal coronaviruses (edit)
Menselijk coronavirus 229E (edit) Biochemical and immunological studies of nucleocapsid proteins of severe acute respiratory syndrome and 229E human coronaviruses. (edit)
Menselijk coronavirus 229E (edit) Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by SARS coronavirus and human coronavirus 229E. (edit)
Menselijk coronavirus 229E (edit) Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit (edit)
Menselijk coronavirus 229E (edit) Exaggerated risk of transmission of COVID-19 by fomites (edit)
Menselijk coronavirus 229E (edit) Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway (edit)
Menselijk coronavirus 229E (edit) Possible involvement of infection with human coronavirus 229E, but not NL63, in Kawasaki disease (edit)
Menselijk coronavirus 229E (edit) Rebuttal to Overinterpretation of the antiviral results for human coronavirus 229E (HCoV-229E) relative to severe acute respiratory syndrome coronavirus -2 (SARS-CoV-2) by Rowpar Pharmaceuticals (edit)
Menselijk coronavirus 229E (edit) Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506. (edit)
Menselijk coronavirus 229E (edit) The ADP-ribose-1''-monophosphatase domains of severe acute respiratory syndrome coronavirus and human coronavirus 229E mediate resistance to antiviral interferon responses (edit)
Menselijk coronavirus 229E (edit) The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways (edit)
Menselijk coronavirus HKU1 (edit) Detection of the human coronavirus 229E, HKU1, NL63, and OC43 between 2010 and 2013 in Yamagata, Japan (edit)
Menselijk coronavirus HKU1 (edit) Human Coronaviruses HCoV-NL63 and HCoV-HKU1 in Hospitalized Children with Acute Respiratory Infections in Beijing, China (edit)
Menselijk coronavirus HKU1 (edit) The novel human coronaviruses NL63 and HKU1. (edit)
Menselijk coronavirus HKU1 (edit) [Development and comparison of real-time and conventional RT-PCR assay for detection of human coronavirus NL63 and HKU1]. (edit)
Menselijk coronavirus OC43 (edit) Detection of the human coronavirus 229E, HKU1, NL63, and OC43 between 2010 and 2013 in Yamagata, Japan (edit)
Menselijk coronavirus OC43 (edit) Genetic variability of human coronavirus OC43-, 229E-, and NL63-like strains and their association with lower respiratory tract infections of hospitalized infants and immunocompromised patients (edit)
Menselijk coronavirus OC43 (edit) An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-reactivity with SARS Coronavirus (edit)
Menselijk coronavirus OC43 (edit) Characterization of human coronavirus OC43 and human coronavirus NL63 infections among hospitalized children <5 years of age. (edit)
Menselijk coronavirus OC43 (edit) Chimeric exchange of coronavirus nsp5 proteases (edit)
Menselijk coronavirus OC43 (edit) Clinical impact of human coronaviruses 229E and OC43 infection in diverse adult populations. (edit)
Menselijk coronavirus OC43 (edit) Coronavirus isolates SK and SD from multiple sclerosis patients are serologically related to murine coronaviruses A59 and JHM and human coronavirus OC43, but not to human coronavirus 229E. (edit)
Menselijk coronavirus OC43 (edit) Exaggerated risk of transmission of COVID-19 by fomites (edit)
Menselijk coronavirus OC43 (edit) False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (edit)
Menselijk coronavirus OC43 (edit) Survival of human coronaviruses 229E and OC43 in suspension and after drying onsurfaces: a possible source ofhospital-acquired infections (edit)
Menselijk coronavirus OC43 (edit) The dominance of human coronavirus OC43 and NL63 infections in infants (edit)
Middle East respiratory syndrome coronavirus (edit) A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets (edit)
Middle East respiratory syndrome coronavirus (edit) Identification, synthesis and evaluation of SARS-CoV and MERS-CoV 3C-like protease inhibitors. (edit)
Middle East respiratory syndrome coronavirus (edit) MERS-CoV: epidemiology, molecular dynamics, therapeutics, and future challenges (edit)
Middle East respiratory syndrome coronavirus (edit) SARS-CoV-2, SARS-CoV and MERS-CoV encode circular RNAs of spliceosome-independent origin (edit)
Middle East respiratory syndrome coronavirus (edit) A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity (edit)
Middle East respiratory syndrome coronavirus (edit) Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond (edit)
Middle East respiratory syndrome coronavirus (edit) Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal coronaviruses (edit)
Middle East respiratory syndrome coronavirus (edit) Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs (edit)
Middle East respiratory syndrome coronavirus (edit) Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains (edit)
Middle East respiratory syndrome coronavirus (edit) Disulfiram can inhibit MERS and SARS coronavirus papain-like proteases via different modes. (edit)
Middle East respiratory syndrome coronavirus (edit) Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV). (edit)
Middle East respiratory syndrome coronavirus (edit) Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines (edit)
Middle East respiratory syndrome coronavirus (edit) Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV (edit)
Middle East respiratory syndrome coronavirus (edit) MOV10 Helicase Interacts with Coronavirus Nucleocapsid Protein and Has Antiviral Activity (edit)
Middle East respiratory syndrome coronavirus (edit) Medusa's ugly head again: from SARS to MERS-CoV. (edit)
Middle East respiratory syndrome coronavirus (edit) Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease (edit)
Middle East respiratory syndrome coronavirus (edit) Middle East respiratory syndrome: SARS redux? (edit)
Middle East respiratory syndrome coronavirus (edit) Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV (edit)
Middle East respiratory syndrome coronavirus (edit) Nsp3 of coronaviruses: Structures and functions of a large multi-domain protein. (edit)
Middle East respiratory syndrome coronavirus (edit) Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review (edit)
Middle East respiratory syndrome coronavirus (edit) Risks to healthcare workers with emerging diseases: lessons from MERS-CoV, Ebola, SARS, and avian flu. (edit)
Middle East respiratory syndrome coronavirus (edit) SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis (edit)
Middle East respiratory syndrome coronavirus (edit) Sensitivity of SARS/MERS CoV to interferons and other drugs based on achievable serum concentrations in humans (edit)
Middle East respiratory syndrome coronavirus (edit) T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV. (edit)
Middle East respiratory syndrome coronavirus (edit) TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection (edit)
Middle East respiratory syndrome coronavirus (edit) The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways (edit)
Middle East respiratory syndrome coronavirus (edit) The enzymatic activity of the nsp14 exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2 (edit)
Middle East respiratory syndrome coronavirus (edit) The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play (edit)
Middle East respiratory syndrome coronavirus (edit) Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)--possible lessons from a systematic review of SARS-CoV therapy (edit)
Middle East respiratory syndrome coronavirus (edit) Travel implications of emerging coronaviruses: SARS and MERS-CoV. (edit)
SARS-CoV-2 (edit) A genome-wide CRISPR screen identifies interactors of the autophagy pathway as conserved coronavirus targets (edit)
SARS-CoV-2 (edit) Comparative protein structure network analysis on 3CLpro from SARS-CoV-1 and SARS-CoV-2 (edit)
SARS-CoV-2 (edit) Computational Saturation Mutagenesis of SARS-CoV-1 Spike Glycoprotein: Stability, Binding Affinity, and Comparison With SARS-CoV-2 (edit)
SARS-CoV-2 (edit) Direct Comparison of N-Glycans and Their Isomers Derived from Spike Glycoprotein 1 of MERS-CoV, SARS-CoV-1, and SARS-CoV-2 (edit)
SARS-CoV-2 (edit) Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD (edit)
SARS-CoV-2 (edit) Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic (edit)
SARS-CoV-2 (edit) Exploiting Connections for Viral Replication (edit)
SARS-CoV-2 (edit) Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches (edit)
SARS-CoV-2 (edit) Long-Term Health Consequences of SARS-CoV-2: Assumptions Based on SARS-CoV-1 and MERS-CoV Infections (edit)
SARS-CoV-2 (edit) MERS-CoV: epidemiology, molecular dynamics, therapeutics, and future challenges (edit)
SARS-CoV-2 (edit) N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition (edit)
SARS-CoV-2 (edit) Novel coronavirus SARS-CoV-2 and COVID-19. Practice recommendations for obstetric anaesthesia: what we have learned thus far (edit)
SARS-CoV-2 (edit) On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2 (edit)
SARS-CoV-2 (edit) Palindromic target site identification in SARS-CoV-2, MERS-CoV and SARS-CoV-1 by adopting CRISPR-Cas technique (edit)
SARS-CoV-2 (edit) SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling (edit)
SARS-CoV-2 (edit) SARS-CoV-2, SARS-CoV and MERS-CoV encode circular RNAs of spliceosome-independent origin (edit)
SARS-CoV-2 (edit) Topological Analysis for Sequence Variability: Case Study on more than 2K SARS-CoV-2 sequences of COVID-19 infected 54 countries in comparison with SARS-CoV-1 and MERS-CoV (edit)
SARS-CoV-2 (edit) A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease (edit)
SARS-CoV-2 (edit) A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) (edit)
SARS-CoV-2 (edit) Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 (edit)
SARS-CoV-2 (edit) Aerosol and surface stability of HCoV-19 (SARS-CoV-2) compared to SARS-CoV-1 (edit)
SARS-CoV-2 (edit) Age-Related Differences in Immunological Responses to SARS-CoV-2 (edit)
SARS-CoV-2 (edit) Autopsy in suspected COVID-19 cases (edit)
SARS-CoV-2 (edit) Bidirectional genome-wide CRISPR screens reveal host factors regulating SARS-CoV-2, MERS-CoV and seasonal coronaviruses (edit)
SARS-CoV-2 (edit) Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike protein (edit)
SARS-CoV-2 (edit) Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs (edit)
SARS-CoV-2 (edit) COVID-19 pneumonia: what has CT taught us? (edit)
SARS-CoV-2 (edit) Case of the Index Patient Who Caused Tertiary Transmission of COVID-19 Infection in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Infected Pneumonia Monitored by Quantitative RT-PCR (edit)
SARS-CoV-2 (edit) Chemokine Regulation During Epidemic Coronavirus Infection (edit)
SARS-CoV-2 (edit) Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past (edit)
SARS-CoV-2 (edit) Commentary: Lethal Pneumonia Cases in Mojiang Miners (2012) and the Mineshaft Could Provide Important Clues to the Origin of SARS-CoV-2 (edit)
SARS-CoV-2 (edit) Comparative dynamic aerosol efficiencies of three emergent coronaviruses and the unusual persistence of SARS-CoV-2 in aerosol suspensions (edit)
SARS-CoV-2 (edit) Comparing the Binding Interactions in the Receptor Binding Domains of SARS-CoV-2 and SARS-CoV (edit)
SARS-CoV-2 (edit) Comprehensive review on the prevailing COVID-19 therapeutics and the potential of repurposing SARS-CoV-1 candidate drugs to target SARS-CoV-2 as a fast-track treatment and prevention option (edit)
SARS-CoV-2 (edit) Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit (edit)
SARS-CoV-2 (edit) Developing antibody tests for SARS-CoV-2 (edit)
SARS-CoV-2 (edit) Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV (edit)
SARS-CoV-2 (edit) Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020 (edit)
SARS-CoV-2 (edit) Exaggerated risk of transmission of COVID-19 by fomites (edit)
SARS-CoV-2 (edit) From SARS and MERS CoVs to SARS‐CoV‐2: Moving toward more biased codon usage in viral structural and nonstructural genes (edit)
SARS-CoV-2 (edit) Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses (edit)
SARS-CoV-2 (edit) Head and neck survivorship care in the times of the SARS-CoV-2 pandemic (edit)
SARS-CoV-2 (edit) High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa (edit)
SARS-CoV-2 (edit) Identification and characterization of circRNAs encoded by MERS-CoV, SARS-CoV-1 and SARS-CoV-2 (edit)
SARS-CoV-2 (edit) Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2 (edit)
SARS-CoV-2 (edit) Increased Incidence, Morbidity, and Mortality in Human Coronavirus NL63 Associated with ACE Inhibitor Therapy and Implication in SARS-CoV-2 (COVID-19) (edit)
SARS-CoV-2 (edit) Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV (edit)
SARS-CoV-2 (edit) Interaction between RAAS inhibitors and ACE2 in the context of COVID-19 (edit)
SARS-CoV-2 (edit) Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins (edit)
SARS-CoV-2 (edit) MOV10 Helicase Interacts with Coronavirus Nucleocapsid Protein and Has Antiviral Activity (edit)
SARS-CoV-2 (edit) Mechanisms of Coronavirus Nsp1-Mediated Control of Host and Viral Gene Expression (edit)
SARS-CoV-2 (edit) Mechanistic insights of host cell fusion of SARS-CoV-1 and SARS-CoV-2 from atomic resolution structure and membrane dynamics (edit)
SARS-CoV-2 (edit) Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2 (edit)
SARS-CoV-2 (edit) Multi-level proteomics reveals host-perturbation strategies of SARS-CoV-2 and SARS-CoV (edit)
SARS-CoV-2 (edit) Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV (edit)
SARS-CoV-2 (edit) Mystery deepens over animal source of coronavirus (edit)
SARS-CoV-2 (edit) Neutralization Assay with SARS-CoV-1 and SARS-CoV-2 Spike Pseudotyped Murine Leukemia Virions (edit)
SARS-CoV-2 (edit) Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV (edit)
SARS-CoV-2 (edit) Ocular tropism of coronavirus (CoVs): a comparison of the interaction between the animal-to-human transmitted coronaviruses (SARS-CoV-1, SARS-CoV-2, MERS-CoV, CoV-229E, NL63, OC43, HKU1) and the eye (edit)
SARS-CoV-2 (edit) On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2 (edit)
SARS-CoV-2 (edit) Part II. High-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced ‘PANIC’ attack (edit)
SARS-CoV-2 (edit) Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway (edit)
SARS-CoV-2 (edit) Potential Rapid Diagnostics, Vaccine and Therapeutics for 2019 Novel Coronavirus (2019-nCoV): A Systematic Review (edit)
SARS-CoV-2 (edit) Potential host range of multiple SARS-like coronaviruses and an improved ACE2-Fc variant that is potent against both SARS-CoV-2 and SARS-CoV-1 (edit)
SARS-CoV-2 (edit) Preparing for emerging respiratory pathogens such as SARS-CoV, MERS-CoV, and SARS-CoV-2 (edit)
SARS-CoV-2 (edit) Rapid Review of SARS-CoV-1 and SARS-CoV-2 Viability, Susceptibility to Treatment, and the Disinfection and Reuse of PPE, Particularly Filtering Facepiece Respirators (edit)
SARS-CoV-2 (edit) Rebuttal to Overinterpretation of the antiviral results for human coronavirus 229E (HCoV-229E) relative to severe acute respiratory syndrome coronavirus -2 (SARS-CoV-2) by Rowpar Pharmaceuticals (edit)
SARS-CoV-2 (edit) Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus (edit)
SARS-CoV-2 (edit) Reply to: 'Interaction between RAAS inhibitors and ACE2 in the context of COVID-19' (edit)
SARS-CoV-2 (edit) SARS-CoV-2 vs. SARS-CoV-1 management: antibiotics and inflammasome modulators potential (edit)
SARS-CoV-2 (edit) SARS-CoV-2's claimed natural origin is undermined by issues with genome sequences of its relative strains: Coronavirus sequences RaTG13, MP789 and RmYN02 raise multiple questions to be critically addressed by the scientific community (edit)
SARS-CoV-2 (edit) SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis (edit)
SARS-CoV-2 (edit) SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway (edit)
SARS-CoV-2 (edit) Sarbecovirus comparative genomics elucidates gene content of SARS-CoV-2 and functional impact of COVID-19 pandemic mutations (edit)
SARS-CoV-2 (edit) Serial co-expression analysis of host factors from SARS-CoV viruses highly converges with former high-throughput screenings and proposes key regulators (edit)
SARS-CoV-2 (edit) Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal Betacoronaviruses (edit)
SARS-CoV-2 (edit) Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group (edit)
SARS-CoV-2 (edit) Shifts in global bat diversity suggest a possible role of climate change in the emergence of SARS-CoV-1 and SARS-CoV-2 (edit)
SARS-CoV-2 (edit) Structure and immune recognition of the porcine epidemic diarrhea virus spike protein (edit)
SARS-CoV-2 (edit) The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner (edit)
SARS-CoV-2 (edit) The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways (edit)
SARS-CoV-2 (edit) The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis (edit)
SARS-CoV-2 (edit) The enzymatic activity of the nsp14 exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2 (edit)
SARS-CoV-2 (edit) The human pandemic coronaviruses on the show: The spike glycoprotein as the main actor in the coronaviruses play (edit)
SARS-CoV-2 (edit) The proximal origin of SARS-CoV-2 (edit)
SARS-CoV-2 (edit) The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 (edit)
SARS-CoV-2 (edit) [Etiology of epidemic outbreaks COVID-19 on Wuhan, Hubei province, Chinese People Republic associated with 2019-nCoV (Nidovirales, Coronaviridae, Coronavirinae, Betacoronavirus, Subgenus Sarbecovirus): lessons of SARS-CoV outbreak.] (edit)
SARS-CoV-2 (edit) [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).] (edit)
SARS-virus (edit) A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice (edit)
SARS-virus (edit) A decade after SARS: strategies for controlling emerging coronaviruses (edit)
SARS-virus (edit) A novel cell-based binding assay system reconstituting interaction between SARS-CoV S protein and its cellular receptor. (edit)
SARS-virus (edit) A preliminary report of SARS coronavirus specific RNA in SARS convalescents and medical person (edit)
SARS-virus (edit) A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice (edit)
SARS-virus (edit) A single amino acid substitution in the S1 and S2 Spike protein domains determines the neutralization escape phenotype of SARS-CoV. (edit)
SARS-virus (edit) A study on antigenicity and receptor-binding ability of fragment 450-650 of the spike protein of SARS coronavirus. (edit)
SARS-virus (edit) Adenoviral expression of a truncated S1 subunit of SARS-CoV spike protein results in specific humoral immune responses against SARS-CoV in rats (edit)
SARS-virus (edit) Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection. (edit)
SARS-virus (edit) Amino acids 1 to 422 of the spike protein of SARS associated coronavirus are required for induction of cyclooxygenase-2. (edit)
SARS-virus (edit) An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus (edit)
SARS-virus (edit) An immunofluorescence assay for the detection of SARS associated coronavirus antibody based on recombinant nucleocapsid antigen and its application (edit)
SARS-virus (edit) Analysis of SARS-CoV receptor activity of ACE2 orthologs (edit)
SARS-virus (edit) Angiotensin-converting enzyme 2 (ACE2) proteins of different bat species confer variable susceptibility to SARS-CoV entry. (edit)
SARS-virus (edit) Anti-HIV, anti-poxvirus, and anti-SARS activity of a nontoxic, acidic plant extract from the Trifollium species Secomet-V/anti-vac suggests that it contains a novel broad-spectrum antiviral. (edit)
SARS-virus (edit) Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity. (edit)
SARS-virus (edit) Antibody-dependent enhancement of SARS coronavirus infection and its role in the pathogenesis of SARS. (edit)
SARS-virus (edit) Autoantibodies against human epithelial cells and endothelial cells after severe acute respiratory syndrome (SARS)-associated coronavirus infection. (edit)
SARS-virus (edit) Bismuth complexes inhibit the SARS coronavirus (edit)
SARS-virus (edit) Characterization of the antiviral effects of interferon-alpha against a SARS-like coronoavirus infection in vitro (edit)
SARS-virus (edit) Clinical evaluation of real-time PCR assays for rapid diagnosis of SARS coronavirus during outbreak and post-epidemic periods (edit)
SARS-virus (edit) Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study (edit)
SARS-virus (edit) Comparative study of clinical characteristics and prognosis of clinically diagnosed SARS patients with positive and negative serum SARS coronavirus-specific antibodies test (edit)
SARS-virus (edit) Computational characterization and design of SARS coronavirus receptor recognition and antibody neutralization (edit)
SARS-virus (edit) Cross-reaction of SARS-CoV antigen with autoantibodies in autoimmune diseases. (edit)
SARS-virus (edit) Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections (edit)
SARS-virus (edit) Derivation of a novel SARS-coronavirus replicon cell line and its application for anti-SARS drug screening (edit)
SARS-virus (edit) Design of recombinant protein-based SARS-CoV entry inhibitors targeting the heptad-repeat regions of the spike protein S2 domain (edit)
SARS-virus (edit) Detection for severe acute respiratory syndrome (SARS) coronavirus RNA in stool of SARS patients (edit)
SARS-virus (edit) Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in sars patients by enzyme-linked immunosorbent assay. (edit)
SARS-virus (edit) Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia. (edit)
SARS-virus (edit) Determination and application of immunodominant regions of SARS coronavirus spike and nucleocapsid proteins recognized by sera from different animal species (edit)
SARS-virus (edit) Development and evaluation of an efficient 3'-noncoding region based SARS coronavirus (SARS-CoV) RT-PCR assay for detection of SARS-CoV infections (edit)
SARS-virus (edit) Development of a SARS Coronavirus Vaccine from Recombinant Spike Protein Plus Delta Inulin Adjuvant (edit)
SARS-virus (edit) Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia. (edit)
SARS-virus (edit) Dynamics of SARS-coronavirus HR2 domain in the prefusion and transition states (edit)
SARS-virus (edit) Early detection of antibodies against various structural proteins of the SARS-associated coronavirus in SARS patients (edit)
SARS-virus (edit) Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients (edit)
SARS-virus (edit) Evaluation of antibody responses against SARS coronaviral nucleocapsid or spike proteins by immunoblotting or ELISA. (edit)
SARS-virus (edit) Evidence for substrate binding-induced zwitterion formation in the catalytic Cys-His dyad of the SARS-CoV main protease (edit)
SARS-virus (edit) Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies (edit)
SARS-virus (edit) Experiences and implications of social workers practicing in a pediatric hospital environment affected by SARS. (edit)
SARS-virus (edit) Exploring the binding mechanism of the main proteinase in SARS-associated coronavirus and its implication to anti-SARS drug design (edit)
SARS-virus (edit) Expression and purification of N and E proteins from severe acute respiratory syndrome (SARS)-associated coronavirus: a comparative study (edit)
SARS-virus (edit) Expression, purification and sublocalization of SARS-CoV nucleocapsid protein in insect cells (edit)
SARS-virus (edit) Features discriminating SARS from other severe viral respiratory tract infections. (edit)
SARS-virus (edit) Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS. (edit)
SARS-virus (edit) High-yield expression of recombinant SARS coronavirus nucleocapsid protein in methylotrophic yeast Pichia pastoris (edit)
SARS-virus (edit) Highly infectious SARS-CoV pseudotyped virus reveals the cell tropism and its correlation with receptor expression (edit)
SARS-virus (edit) How China’s ‘Bat Woman’ Hunted Down Viruses from SARS to the New Coronavirus (edit)
SARS-virus (edit) How change of public transportation usage reveals fear of the SARS virus in a city (edit)
SARS-virus (edit) Human metapneumovirus pneumonia in an adult patient hospitalized for suspected severe acute respiratory syndrome (SARS) (edit)
SARS-virus (edit) Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants (edit)
SARS-virus (edit) Identification of SARS-like coronaviruses in horseshoe bats (Rhinolophus hipposideros) in Slovenia (edit)
SARS-virus (edit) Identification of a Novel Small Molecule Inhibitor Against SARS Coronavirus Helicase (edit)
SARS-virus (edit) Identification of an HLA-A*0201-restricted CD8+ T-cell epitope SSp-1 of SARS-CoV spike protein (edit)
SARS-virus (edit) Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein (edit)
SARS-virus (edit) Identification, synthesis and evaluation of SARS-CoV and MERS-CoV 3C-like protease inhibitors. (edit)
SARS-virus (edit) Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine (edit)
SARS-virus (edit) Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates (edit)
SARS-virus (edit) Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan (edit)
SARS-virus (edit) In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. (edit)
SARS-virus (edit) Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons. (edit)
SARS-virus (edit) Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs. (edit)
SARS-virus (edit) Inhibition of SARS-CoV gene expression by adenovirus-delivered small hairpin RNA. (edit)
SARS-virus (edit) Inhibition of cytokine gene expression and induction of chemokine genes in non-lymphatic cells infected with SARS coronavirus (edit)
SARS-virus (edit) Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics (edit)
SARS-virus (edit) Interactions between SARS coronavirus and its receptor (edit)
SARS-virus (edit) Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV). (edit)
SARS-virus (edit) International research networks in viral structural proteomics: again, lessons from SARS. (edit)
SARS-virus (edit) Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China (edit)
SARS-virus (edit) Isolation of virus from a SARS patient and genome-wide analysis of genetic mutations related to pathogenesis and epidemiology from 47 SARS-CoV isolates (edit)
SARS-virus (edit) Kinetics and synergistic effects of siRNAs targeting structural and replicase genes of SARS-associated coronavirus. (edit)
SARS-virus (edit) Kinetics of severe acute respiratory syndrome (SARS) coronavirus-specific antibodies in 271 laboratory-confirmed cases of SARS (edit)
SARS-virus (edit) Large-scale preparation of UV-inactivated SARS coronavirus virions for vaccine antigen (edit)
SARS-virus (edit) Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine (edit)
SARS-virus (edit) Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus (edit)
SARS-virus (edit) Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic Viruses (edit)
SARS-virus (edit) Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection (edit)
SARS-virus (edit) Mustela vison ACE2 functions as a receptor for SARS-coronavirus (edit)
SARS-virus (edit) Mutation analysis of 20 SARS virus genome sequences: evidence for negative selection in replicase ORF1b and spike gene (edit)
SARS-virus (edit) New Potent SARS-CoV 3C-Like Protease Inhibitors Derived from Thieno[2,3-d]-pyrimidine Derivatives. (edit)
SARS-virus (edit) Novel Alphacoronaviruses and Paramyxoviruses Cocirculate with Type 1 and Severe Acute Respiratory System (SARS)-Related Betacoronaviruses in Synanthropic Bats of Luxembourg (edit)
SARS-virus (edit) Pathological Clues to How the SARS Virus Kills (edit)
SARS-virus (edit) Pathology of guinea pigs experimentally infected with a novel reovirus and coronavirus isolated from SARS patients (edit)
SARS-virus (edit) Persistent infection of SARS coronavirus in colonic cells in vitro. (edit)
SARS-virus (edit) Phosphorylation of p38 MAPK and its downstream targets in SARS coronavirus-infected cells (edit)
SARS-virus (edit) Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid (edit)
SARS-virus (edit) Potent inhibition of SARS-associated coronavirus (SCOV) infection and replication by type I interferons (IFN-alpha/beta) but not by type II interferon (IFN-gamma). (edit)
SARS-virus (edit) Preparation and characterization of monoclonal antibodies against S1 domain at N-terminal residues 249 to 667 of SARS-associated coronavirus S1 protein. (edit)
SARS-virus (edit) Preparation and evaluation of anti-SARS coronavirus IgY from yolks of immunized SPF chickens (edit)
SARS-virus (edit) Prevalence of non-pneumonic infections with SARS-correlated virus. (edit)
SARS-virus (edit) Primary characterization of SARS coronavirus strain Frankfurt 1. (edit)
SARS-virus (edit) Production of a monoclonal antibody against SARS-CoV spike protein with single intrasplenic immunization of plasmid DNA. (edit)
SARS-virus (edit) Profile of antibodies to the nucleocapsid protein of the severe acute respiratory syndrome (SARS)-associated coronavirus in probable SARS patients. (edit)
SARS-virus (edit) Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids (edit)
SARS-virus (edit) Promoter activity of SARS coronavirus 5' UTR sequence in eukaryotic cells. (edit)
SARS-virus (edit) Prophylactic and therapeutic effects of small interfering RNA targeting SARS-coronavirus (edit)
SARS-virus (edit) Pseudotyped vesicular stomatitis virus for functional analysis of SARS coronavirus spike protein (edit)
SARS-virus (edit) Quantitative analysis and prognostic implication of SARS coronavirus RNA in the plasma and serum of patients with severe acute respiratory syndrome. (edit)
SARS-virus (edit) Quantitative comparison of the efficiency of antibodies against S1 and S2 subunit of SARS coronavirus spike protein in virus neutralization and blocking of receptor binding: implications for the functional roles of S2 subunit (edit)
SARS-virus (edit) Quantitative evaluation of infection control models in the prevention of nosocomial transmission of SARS virus to healthcare workers: implication to nosocomial viral infection control for healthcare workers (edit)
SARS-virus (edit) Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine (edit)
SARS-virus (edit) Recombinant adeno-associated virus expressing the receptor-binding domain of severe acute respiratory syndrome coronavirus S protein elicits neutralizing antibodies: Implication for developing SARS vaccines (edit)
SARS-virus (edit) Recombinant protein-based enzyme-linked immunosorbent assay and immunochromatographic tests for detection of immunoglobulin G antibodies to severe acute respiratory syndrome (SARS) coronavirus in SARS patients. (edit)
SARS-virus (edit) Recurrent mutations associated with isolation and passage of SARS coronavirus in cells from non-human primates (edit)
SARS-virus (edit) Reliability of detecting SARS-CoV antibody for diagnosis of SARS (edit)
SARS-virus (edit) Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines. (edit)
SARS-virus (edit) SARS coronavirus induces apoptosis in Vero E6 cells (edit)
SARS-virus (edit) SARS coronavirus nucleocapsid immunodominant T-cell epitope cluster is common to both exogenous recombinant and endogenous DNA-encoded immunogens (edit)
SARS-virus (edit) SARS coronavirus papain-like protease up-regulates the collagen expression through non-Samd TGF-β1 signaling (edit)
SARS-virus (edit) SARS-CoV and IFN: Too Little, Too Late. (edit)
SARS-virus (edit) SARS-CoV infection and pregnancy (edit)
SARS-virus (edit) SARS-CoV nucleocapsid protein induced apoptosis of COS-1 mediated by the mitochondrial pathway (edit)
SARS-virus (edit) SARS-CoV, but not HCoV-NL63, utilizes cathepsins to infect cells: viral entry (edit)
SARS-virus (edit) SARS-associated coronavirus gene fragments were detected from a suspected pediatric SARS patient (edit)
SARS-virus (edit) SARS-associated coronavirus replication in cell lines (edit)
SARS-virus (edit) SARS-unique fold in the Rousettus bat coronavirus HKU9. (edit)
SARS-virus (edit) Self-assembly of a nine-residue amyloid-forming peptide fragment of SARS corona virus E-protein: mechanism of self aggregation and amyloid-inhibition of hIAPP. (edit)
SARS-virus (edit) Severe Acute Respiratory Syndrome (SARS) Coronavirus ORF8 Protein Is Acquired from SARS-Related Coronavirus from Greater Horseshoe Bats through Recombination (edit)
SARS-virus (edit) Severe acute respiratory syndrome (SARS) coronavirus: possible re-emergence of the Asian-global novel threat. (edit)
SARS-virus (edit) Signal transduction in SARS-CoV-infected cells (edit)
SARS-virus (edit) Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference (edit)
SARS-virus (edit) Silencing of SARS-CoV spike gene by small interfering RNA in HEK 293T cells (edit)
SARS-virus (edit) Small interfering RNA inhibits SARS-CoV nucleocapsid gene expression in cultured cells and mouse muscles (edit)
SARS-virus (edit) Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation. (edit)
SARS-virus (edit) Suppression of SARS-CoV entry by peptides corresponding to heptad regions on spike glycoprotein (edit)
SARS-virus (edit) Susceptibility of different eukaryotic cell lines to SARS-coronavirus. (edit)
SARS-virus (edit) Susceptibility of human and rat neural cell lines to infection by SARS-coronavirus (edit)
SARS-virus (edit) Susceptibility to SARS coronavirus S protein-driven infection correlates with expression of angiotensin converting enzyme 2 and infection can be blocked by soluble receptor (edit)
SARS-virus (edit) Synergistic inhibition of SARS-coronavirus replication by type I and type II IFN. (edit)
SARS-virus (edit) Synthesis and evaluation of phenylisoserine derivatives for the SARS-CoV 3CL protease inhibitor (edit)
SARS-virus (edit) Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor (edit)
SARS-virus (edit) Synthetic peptide studies on the severe acute respiratory syndrome (SARS) coronavirus spike glycoprotein: perspective for SARS vaccine development (edit)
SARS-virus (edit) Synthetic peptides outside the spike protein heptad repeat regions as potent inhibitors of SARS-associated coronavirus (edit)
SARS-virus (edit) The nsp2 proteins of mouse hepatitis virus and SARS coronavirus are dispensable for viral replication (edit)
SARS-virus (edit) The severe acute respiratory syndrome (SARS) coronavirus NTPase/helicase belongs to a distinct class of 5' to 3' viral helicases. (edit)
SARS-virus (edit) Tracking the evolution of the SARS coronavirus using high-throughput, high-density resequencing arrays (edit)
SARS-virus (edit) Transcriptional profiling of Vero E6 cells over-expressing SARS-CoV S2 subunit: insights on viral regulation of apoptosis and proliferation (edit)
SARS-virus (edit) Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). (edit)
SARS-virus (edit) Two-amino acids change in the nsp4 of SARS coronavirus abolishes viral replication (edit)
SARS-virus (edit) Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses (edit)
SARS-virus (edit) Virus-associated hemophagocytic syndrome in an international traveler as a differential diagnosis of SARS. (edit)
SARS-virus (edit) Why viral (SARS, Ebola and AIDS) epidemics now? (edit)
SARS-virus (edit) siRNAs targeting terminal sequences of the SARS-associated coronavirus membrane gene inhibit M protein expression through degradation of M mRNA. (edit)
SARS-virus (edit) 1H, 13C and 15N resonance assignments of SARS-CoV main protease N-terminal domain. (edit)
SARS-virus (edit) 2,6-Bis-arylmethyloxy-5-hydroxychromones with antiviral activity against both hepatitis C virus (HCV) and SARS-associated coronavirus (SCV). (edit)
SARS-virus (edit) A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity (edit)
SARS-virus (edit) A 3D model of SARS_CoV 3CL proteinase and its inhibitors design by virtual screening. (edit)
SARS-virus (edit) A Novel Chemical Compound for Inhibition of SARS Coronavirus Helicase. (edit)
SARS-virus (edit) A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence (edit)
SARS-virus (edit) A chimeric multi-epitope DNA vaccine elicited specific antibody response against severe acute respiratory syndrome-associated coronavirus which attenuated the virulence of SARS-CoV in vitro. (edit)
SARS-virus (edit) A climatologic investigation of the SARS-CoV outbreak in Beijing, China. (edit)
SARS-virus (edit) A convenient cell fusion assay for the study of SARS-CoV entry and inhibition. (edit)
SARS-virus (edit) A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury (edit)
SARS-virus (edit) A dominant antigenic epitope on SARS-CoV spike protein identified by an avian single-chain variable fragment (edit)
SARS-virus (edit) A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses. (edit)
SARS-virus (edit) A facile inhibitor screening of SARS coronavirus N protein using nanoparticle-based RNA oligonucleotide (edit)
SARS-virus (edit) A fluorogenic peptide containing the processing site of human SARS corona virus S-protein: kinetic evaluation and NMR structure elucidation. (edit)
SARS-virus (edit) A genome sequence of novel SARS-CoV isolates: the genotype, GD-Ins29, leads to a hypothesis of viral transmission in South China. (edit)
SARS-virus (edit) A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2. (edit)
SARS-virus (edit) A human SARS-CoV neutralizing antibody against epitope on S2 protein (edit)
SARS-virus (edit) A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infection (edit)
SARS-virus (edit) A molecular docking model of SARS-CoV S1 protein in complex with its receptor, human ACE2. (edit)
SARS-virus (edit) A monomer-dimer nanoswitch that mimics the working principle of the SARS-CoV 3CLpro enzyme controls copper-catalysed cyclopropanation. (edit)
SARS-virus (edit) A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice (edit)
SARS-virus (edit) A network integration approach to predict conserved regulators related to pathogenicity of influenza and SARS-CoV respiratory viruses (edit)
SARS-virus (edit) A new infectious disease challenge: Urbani severe acute respiratory syndrome (SARS) associated coronavirus (edit)
SARS-virus (edit) A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo (edit)
SARS-virus (edit) A new nucleotide-composition based fingerprint of SARS-CoV with visualization analysis (edit)
SARS-virus (edit) A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication (edit)
SARS-virus (edit) A novel fingerprint map for detecting SARS-CoV. (edit)
SARS-virus (edit) A novel subset of putative stem/progenitor CD34+Oct-4+ cells is the major target for SARS coronavirus in human lung. (edit)
SARS-virus (edit) A one step quantitative RT-PCR for detection of SARS coronavirus with an internal control for PCR inhibitors. (edit)
SARS-virus (edit) A putative diacidic motif in the SARS-CoV ORF6 protein influences its subcellular localization and suppression of expression of co-transfected expression constructs. (edit)
SARS-virus (edit) A rapid point of care immunoswab assay for SARS-CoV detection (edit)
SARS-virus (edit) A real-time PCR assay for bat SARS-like coronavirus detection and its application to Italian greater horseshoe bat faecal sample surveys. (edit)
SARS-virus (edit) A real-time PCR for SARS-coronavirus incorporating target gene pre-amplification (edit)
SARS-virus (edit) A simple and rapid approach for screening of SARS-coronavirus genotypes: an evaluation study (edit)
SARS-virus (edit) A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (edit)
SARS-virus (edit) A strategy for searching antigenic regions in the SARS-CoV spike protein. (edit)
SARS-virus (edit) A structural view of the inactivation of the SARS coronavirus main proteinase by benzotriazole esters (edit)
SARS-virus (edit) A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice. (edit)
SARS-virus (edit) A three-stemmed mRNA pseudoknot in the SARS coronavirus frameshift signal (edit)
SARS-virus (edit) A throat lozenge containing amyl meta cresol and dichlorobenzyl alcohol has a direct virucidal effect on respiratory syncytial virus, influenza A and SARS-CoV (edit)
SARS-virus (edit) A universal microarray for detection of SARS coronavirus. (edit)
SARS-virus (edit) ACE2: from vasopeptidase to SARS virus receptor (edit)
SARS-virus (edit) Accelerated induction of apoptosis in insect cells by baculovirus-expressed SARS-CoV membrane protein (edit)
SARS-virus (edit) Accumulation of recombinant SARS-CoV spike protein in plant cytosol and chloroplasts indicate potential for development of plant-derived oral vaccines (edit)
SARS-virus (edit) Acquisition of new protein domains by coronaviruses: analysis of overlapping genes coding for proteins N and 9b in SARS coronavirus (edit)
SARS-virus (edit) Adaptive evolution of the spike gene of SARS coronavirus: changes in positively selected sites in different epidemic groups. (edit)
SARS-virus (edit) Aetiology: Koch's postulates fulfilled for SARS virus (edit)
SARS-virus (edit) Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model (edit)
SARS-virus (edit) Allelic Variation in the Toll-Like Receptor Adaptor Protein Ticam2 Contributes to SARS-Coronavirus Pathogenesis in Mice. (edit)
SARS-virus (edit) Amino acids 15-28 in the ectodomain of SARS coronavirus 3a protein induces neutralizing antibodies (edit)
SARS-virus (edit) Amiodarone alters late endosomes and inhibits SARS coronavirus infection at a post-endosomal level. (edit)
SARS-virus (edit) An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-reactivity with SARS Coronavirus (edit)
SARS-virus (edit) An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy. (edit)
SARS-virus (edit) An atypical RNA pseudoknot stimulator and an upstream attenuation signal for -1 ribosomal frameshifting of SARS coronavirus (edit)
SARS-virus (edit) An efficient RNA-cleaving DNA enzyme can specifically target the 5'-untranslated region of severe acute respiratory syndrome associated coronavirus (edit)
SARS-virus (edit) An efficient method for the synthesis of peptide aldehyde libraries employed in the discovery of reversible SARS coronavirus main protease (SARS-CoV Mpro) inhibitors (edit)
SARS-virus (edit) An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. (edit)
SARS-virus (edit) An immunosuppressed Syrian golden hamster model for SARS-CoV infection (edit)
SARS-virus (edit) An initial investigation of the association between the SARS outbreak and weather: with the view of the environmental temperature and its variation (edit)
SARS-virus (edit) An oral mucosal DNA vaccine for SARS coronavirus infections. (edit)
SARS-virus (edit) An overall picture of SARS coronavirus (SARS-CoV) genome-encoded major proteins: structures, functions and drug development (edit)
SARS-virus (edit) Analysis of synonymous codon usage in SARS Coronavirus and other viruses in the Nidovirales. (edit)
SARS-virus (edit) Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus (edit)
SARS-virus (edit) Animal coronavirus vaccines: lessons for SARS. (edit)
SARS-virus (edit) Animal models and vaccines for SARS-CoV infection. (edit)
SARS-virus (edit) Animal models for SARS and MERS coronaviruses (edit)
SARS-virus (edit) Animal origins of SARS coronavirus: possible links with the international trade in small carnivores (edit)
SARS-virus (edit) Animal reservoirs for SARS-like coronavirus in southern China. (edit)
SARS-virus (edit) Animal-to-human SARS-associated coronavirus transmission? (edit)
SARS-virus (edit) Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds. (edit)
SARS-virus (edit) Anti-SARS coronavirus 3C-like protease effects of Rheum palmatum L. extracts. (edit)
SARS-virus (edit) Anti-SARS coronavirus agents: a patent review (2008 - present). (edit)
SARS-virus (edit) Anti-SARS virus antibody responses against human SARS-associated coronavirus and animal SARS-associated coronavirus-like virus. (edit)
SARS-virus (edit) Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome. (edit)
SARS-virus (edit) Anti-SARS-CoV activity of nucleoside analogs having 6-chloropurine as a nucleobase. (edit)
SARS-virus (edit) Anti-SARS-CoV immunoglobulin G in healthcare workers, Guangzhou, China (edit)
SARS-virus (edit) Anti-frameshifting ligand reduces the conformational plasticity of the SARS virus pseudoknot. (edit)
SARS-virus (edit) Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro. (edit)
SARS-virus (edit) Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC. (edit)
SARS-virus (edit) Antibodies to SARS coronavirus in civets (edit)
SARS-virus (edit) Antibodies to SARS-like virus hint at repeated infections. (edit)
SARS-virus (edit) Antibody binding site mapping of SARS-CoV spike protein receptor-binding domain by a combination of yeast surface display and phage peptide library screening (edit)
SARS-virus (edit) Antibody response and viraemia during the course of severe acute respiratory syndrome (edit)
SARS-virus (edit) Antibody response of patients with severe acute respiratory syndrome (edit)
SARS-virus (edit) Antibody responses against SARS coronavirus are correlated with disease outcome of infected individuals. (edit)
SARS-virus (edit) Antibody responses against SARS-coronavirus and its nucleocaspid in SARS patients. (edit)
SARS-virus (edit) Antibody responses to individual proteins of SARS coronavirus and their neutralization activities. (edit)
SARS-virus (edit) Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins (edit)
SARS-virus (edit) Antibody-mediated synergy and interference in the neutralization of SARS-CoV at an epitope cluster on the spike protein. (edit)
SARS-virus (edit) Antigenic cross-reactivity between the nucleocapsid protein of severe acute respiratory syndrome (edit)
SARS-virus (edit) Antigenicity and immunogenicity of SARS-CoV S protein receptor-binding domain stably expressed in CHO cells (edit)
SARS-virus (edit) Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein. (edit)
SARS-virus (edit) Antisense downregulation of SARS-CoV gene expression in Vero E6 cells. (edit)
SARS-virus (edit) Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus. (edit)
SARS-virus (edit) Antiviral agents and corticosteroids in the treatment of severe acute respiratory syndrome (edit)
SARS-virus (edit) Antiviral drug discovery against SARS-CoV. (edit)
SARS-virus (edit) Antiviral treatment of SARS: can we draw any conclusions? (edit)
SARS-virus (edit) Apoptosis induced by the SARS-associated coronavirus in Vero cells is replication-dependent and involves caspase. (edit)
SARS-virus (edit) Application of bioinformatics in search for cleavable peptides of SARS-CoV M(pro) and chemical modification of octapeptides (edit)
SARS-virus (edit) Application of real-time PCR for testing antiviral compounds against Lassa virus, SARS coronavirus and Ebola virus in vitro (edit)
SARS-virus (edit) Applying lessons from SARS to a newly identified coronavirus. (edit)
SARS-virus (edit) Aryl methylene ketones and fluorinated methylene ketones as reversible inhibitors for severe acute respiratory syndrome (edit)
SARS-virus (edit) Assays for the assessment of neutralizing antibody activities against Severe Acute Respiratory Syndrome (SARS) associated coronavirus (SCV). (edit)
SARS-virus (edit) Assembling the SARS-CoV genome -- new method based on graph theoretical approach. (edit)
SARS-virus (edit) Asymptomatic SARS coronavirus infection among healthcare workers, Singapore (edit)
SARS-virus (edit) Asymptomatic animal traders prove positive for SARS virus. (edit)
SARS-virus (edit) Attachment factor and receptor engagement of SARS coronavirus and human coronavirus NL63. (edit)
SARS-virus (edit) Attenuation of SARS coronavirus by a short hairpin RNA expression plasmid targeting RNA-dependent RNA polymerase. (edit)
SARS-virus (edit) Augmentation of immune responses to SARS coronavirus by a combination of DNA and whole killed virus vaccines. (edit)
SARS-virus (edit) Automated extraction protocol for quantification of SARS-coronavirus RNA in serum: an evaluation study (edit)
SARS-virus (edit) Baculovirus surface display of SARS coronavirus (edit)
SARS-virus (edit) Bat cave solves mystery of deadly SARS virus - and suggests new outbreak could occur. (edit)
SARS-virus (edit) Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond (edit)
SARS-virus (edit) Bats and emerging zoonoses: henipaviruses and SARS. (edit)
SARS-virus (edit) Bats are natural reservoirs of SARS-like coronaviruses (edit)
SARS-virus (edit) Bats as animal reservoirs for the SARS coronavirus: hypothesis proved after 10 years of virus hunting. (edit)
SARS-virus (edit) Bcl-2 inhibits the caspase-dependent apoptosis induced by SARS-CoV without affecting virus replication kinetics. (edit)
SARS-virus (edit) Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL (edit)
SARS-virus (edit) Binding interaction of SARS coronavirus 3CL(pro) protease with vacuolar-H+ ATPase G1 subunit (edit)
SARS-virus (edit) Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. (edit)
SARS-virus (edit) Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. (edit)
SARS-virus (edit) Bioinformatics analysis of SARS coronavirus genome polymorphism (edit)
SARS-virus (edit) Bioinformatics research on the SARS coronavirus (SARS_CoV) in China (edit)
SARS-virus (edit) Bioterrorism and emerging infectious disease - antimicrobials, therapeutics and immune-modulators. SARS coronavirus. (edit)
SARS-virus (edit) Boosted expression of the SARS-CoV nucleocapsid protein in tobacco and its immunogenicity in mice. (edit)
SARS-virus (edit) Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway (edit)
SARS-virus (edit) CD8+ T cell response in HLA-A*0201 transgenic mice is elicited by epitopes from SARS-CoV S protein. (edit)
SARS-virus (edit) Candidate genes associated with susceptibility for SARS-coronavirus (edit)
SARS-virus (edit) Cell entry by enveloped viruses: redox considerations for HIV and SARS-coronavirus (edit)
SARS-virus (edit) Cellular entry of the SARS coronavirus (edit)
SARS-virus (edit) Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection (edit)
SARS-virus (edit) Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV. (edit)
SARS-virus (edit) Challenges presented by MERS corona virus, and SARS corona virus to global health (edit)
SARS-virus (edit) Changing virulence of the SARS virus: the epidemiological evidence. (edit)
SARS-virus (edit) Characterisation of animal angiotensin-converting enzyme 2 receptors and use of pseudotyped virus to correlate receptor binding with susceptibility of SARS-CoV infection. (edit)
SARS-virus (edit) Characterization and application of monoclonal antibodies against N protein of SARS-coronavirus. (edit)
SARS-virus (edit) Characterization and inhibition of SARS-coronavirus main protease (edit)
SARS-virus (edit) Characterization of Persistent SARS-CoV Infection in Vero E6 Cells (edit)
SARS-virus (edit) Characterization of SARS-CoV main protease and identification of biologically active small molecule inhibitors using a continuous fluorescence-based assay. (edit)
SARS-virus (edit) Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection. (edit)
SARS-virus (edit) Characterization of cytotoxic T-lymphocyte epitopes and immune responses to SARS coronavirus spike DNA vaccine expressing the RGD-integrin-binding motif. (edit)
SARS-virus (edit) Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS-CoV spike gene fragments. (edit)
SARS-virus (edit) Characterization of monoclonal antibody against SARS coronavirus nucleocapsid antigen and development of an antigen capture ELISA. (edit)
SARS-virus (edit) Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (edit)
SARS-virus (edit) Characterization of protein-protein interactions between the nucleocapsid protein and membrane protein of the SARS coronavirus. (edit)
SARS-virus (edit) Characterization of the heptad repeat regions, HR1 and HR2, and design of a fusion core structure model of the spike protein from severe acute respiratory syndrome (SARS) coronavirus. (edit)
SARS-virus (edit) Characterization of viral proteins encoded by the SARS-coronavirus genome. (edit)
SARS-virus (edit) Characterizing 56 complete SARS-CoV S-gene sequences from Hong Kong. (edit)
SARS-virus (edit) Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells. (edit)
SARS-virus (edit) Chicken single-chain variable fragments against the SARS-CoV spike protein. (edit)
SARS-virus (edit) Children's vaccines do not induce cross reactivity against SARS-CoV. (edit)
SARS-virus (edit) Chloroquine is a potent inhibitor of SARS coronavirus infection and spread (edit)
SARS-virus (edit) Chronological evolution of IgM, IgA, IgG and neutralisation antibodies after infection with SARS-associated coronavirus. (edit)
SARS-virus (edit) Cleavage of spike protein of SARS coronavirus by protease factor Xa is associated with viral infectivity (edit)
SARS-virus (edit) Cloaked similarity between HIV-1 and SARS-CoV suggests an anti-SARS strategy (edit)
SARS-virus (edit) Cloning, expression, and purification of the nucleocapsid protein of SARS coronavirus. (edit)
SARS-virus (edit) Cloning, sequencing, expression, and purification of SARS-associated coronavirus nucleocapsid protein for serodiagnosis of SARS. (edit)
SARS-virus (edit) Combination of functionalized nanoparticles and polymerase chain reaction-based method for SARS-CoV gene detection. (edit)
SARS-virus (edit) Comparative analysis of the SARS coronavirus genome: a good start to a long journey (edit)
SARS-virus (edit) Comparative analysis of the immunogenicity of SARS-CoV nucleocapsid DNA vaccine administrated with different routes in mouse model. (edit)
SARS-virus (edit) Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. (edit)
SARS-virus (edit) Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by SARS coronavirus and human coronavirus 229E. (edit)
SARS-virus (edit) Comparative immunization in BALB/c mice with recombinant replication-defective adenovirus vector and DNA plasmid expressing a SARS-CoV nucleocapsid protein gene. (edit)
SARS-virus (edit) Comparative pathogenesis of three human and zoonotic SARS-CoV strains in cynomolgus macaques (edit)
SARS-virus (edit) Comparison of immunoglobulin G responses to the spike and nucleocapsid proteins of severe acute respiratory syndrome (SARS) coronavirus in patients with SARS (edit)
SARS-virus (edit) Complete genome sequences of the SARS-CoV: the BJ Group (edit)
SARS-virus (edit) Comprehensive antibody epitope mapping of the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus: insight into the humoral immunity of SARS. (edit)
SARS-virus (edit) Comprehensive detection and identification of human coronaviruses, including the SARS-associated coronavirus, with a single RT-PCR assay. (edit)
SARS-virus (edit) Concentration and detection of SARS coronavirus in sewage from Xiao Tang Shan Hospital and the 309th Hospital of the Chinese People's Liberation Army. (edit)
SARS-virus (edit) Concentration and detection of SARS coronavirus in sewage from Xiao Tang Shan Hospital and the 309th Hospital. (edit)
SARS-virus (edit) Conductance and amantadine binding of a pore formed by a lysine-flanked transmembrane domain of SARS coronavirus envelope protein (edit)
SARS-virus (edit) Conference report - II. Investigating new vaccines: SARS. Highlights from the Viral Vaccine Meeting; October 25-28, 2003; Barcelona, Spain. (edit)
SARS-virus (edit) Construction and screening of SARS-CoV S protein-specific phage displayed antigen library (edit)
SARS-virus (edit) Construction of a eukaryotic expression plasmid encoding partial S gene fragments of the SARS-CoV and its potential utility as a DNA vaccine. (edit)
SARS-virus (edit) Construction of a large human scFv library against SARS virus (edit)
SARS-virus (edit) Construction of a non-infectious SARS coronavirus replicon for application in drug screening and analysis of viral protein function. (edit)
SARS-virus (edit) Construction of phage antibody library for Fab fragment from a convalescent patient infected with SARS coronavirus (edit)
SARS-virus (edit) Coordinate induction of IFN-alpha and -gamma by SARS-CoV also in the absence of virus replication. (edit)
SARS-virus (edit) Copious production of SARS-CoV nucleocapsid protein employing codon optimized synthetic gene. (edit)
SARS-virus (edit) Coronaviridae and SARS-associated coronavirus strain HSR1. (edit)
SARS-virus (edit) Coronavirus 3CLpro proteinase cleavage sites: possible relevance to SARS virus pathology (edit)
SARS-virus (edit) Coronavirus in severe acute respiratory syndrome (SARS). (edit)
SARS-virus (edit) Coronavirus outbreak in cheetahs: lessons for SARS. (edit)
SARS-virus (edit) Coronavirus replication and pathogenesis: Implications for the recent outbreak of severe acute respiratory syndrome (SARS), and the challenge for vaccine development. (edit)
SARS-virus (edit) Coronaviruses post-SARS: update on replication and pathogenesis (edit)
SARS-virus (edit) Correction: Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus. (edit)
SARS-virus (edit) Correction: SARS Coronavirus 3b Accessory Protein Modulates Transcriptional Activity of RUNX1b. (edit)
SARS-virus (edit) Correction: Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants. (edit)
SARS-virus (edit) Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses. (edit)
SARS-virus (edit) Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (edit)
SARS-virus (edit) Cross-reactivity of antibody against SARS-coronavirus nucleocapsid protein with IL-11. (edit)
SARS-virus (edit) Crystal structures reveal an induced-fit binding of a substrate-like Aza-peptide epoxide to SARS coronavirus main peptidase (edit)
SARS-virus (edit) Crystallization and diffraction analysis of the SARS coronavirus nsp10-nsp16 complex (edit)
SARS-virus (edit) Crystallization and preliminary crystallographic analysis of the heptad-repeat complex of SARS coronavirus spike protein. (edit)
SARS-virus (edit) Cxcl16 interact with SARS-CoV N protein in and out cell (edit)
SARS-virus (edit) Date of origin of the SARS coronavirus strains (edit)
SARS-virus (edit) Deciphering the biosynthetic codes for the potent anti-SARS-CoV cyclodepsipeptide valinomycin in Streptomyces tsusimaensis ATCC 15141. (edit)
SARS-virus (edit) Dendritic cell targeted chitosan nanoparticles for nasal DNA immunization against SARS CoV nucleocapsid protein (edit)
SARS-virus (edit) Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction. (edit)
SARS-virus (edit) Design and synthesis of a series of serine derivatives as small molecule inhibitors of the SARS coronavirus 3CL protease (edit)
SARS-virus (edit) Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (edit)
SARS-virus (edit) Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety. (edit)
SARS-virus (edit) Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors (edit)
SARS-virus (edit) Design, synthesis and screening of antisense peptide based combinatorial peptide libraries towards an aromatic region of SARS-CoV. (edit)
SARS-virus (edit) Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: structure-activity relationship study. (edit)
SARS-virus (edit) Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease. (edit)
SARS-virus (edit) Detecting specific cytotoxic T lymphocytes against SARS-coronavirus with DimerX HLA-A2:Ig fusion protein. (edit)
SARS-virus (edit) Detection and monitoring of SARS coronavirus in the plasma and peripheral blood lymphocytes of patients with severe acute respiratory syndrome. (edit)
SARS-virus (edit) Detection of SARS coronavirus (edit)
SARS-virus (edit) Detection of SARS coronavirus RNA in the cerebrospinal fluid of a patient with severe acute respiratory syndrome. (edit)
SARS-virus (edit) Detection of SARS coronavirus in humans and animals by conventional and quantitative (edit)
SARS-virus (edit) Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays. (edit)
SARS-virus (edit) Detection of SARS coronavirus in patients with suspected SARS (edit)
SARS-virus (edit) Detection of SARS coronavirus in plasma by real-time RT-PCR. (edit)
SARS-virus (edit) Detection of SARS-associated coronavirus in throat wash and saliva in early diagnosis (edit)
SARS-virus (edit) Detection of airborne severe acute respiratory syndrome (edit)
SARS-virus (edit) Detection of antibodies against SARS-CoV in serum from SARS-infected donors with ELISA and Western blot. (edit)
SARS-virus (edit) Detection of novel SARS-like and other coronaviruses in bats from Kenya (edit)
SARS-virus (edit) Determination of SARS-coronavirus by a microfluidic chip system (edit)
SARS-virus (edit) Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus. (edit)
SARS-virus (edit) Development and evaluation of an enzyme-linked immunosorbent assay for detection of antibodies against the spike protein of SARS-coronavirus. (edit)
SARS-virus (edit) Development and validation of a high-throughput screen for inhibitors of SARS CoV and its application in screening of a 100,000-compound library (edit)
SARS-virus (edit) Development of Taqman RT-nested PCR system for clinical SARS-CoV detection. (edit)
SARS-virus (edit) Development of a chimeric DNA-RNA hammerhead ribozyme targeting SARS virus (edit)
SARS-virus (edit) Development of a dose-response model for SARS coronavirus. (edit)
SARS-virus (edit) Development of a method for concentrating and purifying SARS coronavirus RNA by a magnetic bead capture system. (edit)
SARS-virus (edit) Development of a molecular-beacon-based multi-allelic real-time RT-PCR assay for the detection of human coronavirus causing severe acute respiratory syndrome (edit)
SARS-virus (edit) Development of a quantitative assay for SARS coronavirus and correlation of GAPDH mRNA with SARS coronavirus in clinical specimens (edit)
SARS-virus (edit) Development of a red-shifted fluorescence-based assay for SARS-coronavirus 3CL protease: identification of a novel class of anti-SARS agents from the tropical marine sponge Axinella corrugata (edit)
SARS-virus (edit) Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein. (edit)
SARS-virus (edit) Development of a single nucleotide polymorphism DNA microarray for the detection and genotyping of the SARS coronavirus (edit)
SARS-virus (edit) Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus (edit)
SARS-virus (edit) Development of chemical inhibitors of the SARS coronavirus: viral helicase as a potential target (edit)
SARS-virus (edit) Development of human single-chain antibodies against SARS-associated coronavirus (edit)
SARS-virus (edit) Development of mouse hepatitis virus and SARS-CoV infectious cDNA constructs (edit)
SARS-virus (edit) Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: design, synthesis, biological evaluation, and docking studies. (edit)
SARS-virus (edit) Development of vaccines and passive immunotherapy against SARS corona virus using SCID-PBL/hu mouse models. (edit)
SARS-virus (edit) Diagnosis of severe acute respiratory syndrome (edit)
SARS-virus (edit) Diagnostics of severe acute respiratory syndrome-associated coronavirus (edit)
SARS-virus (edit) Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava. (edit)
SARS-virus (edit) Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin (edit)
SARS-virus (edit) Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2. (edit)
SARS-virus (edit) Differential characteristics of the early stage of lung inflammation induced by SARS-CoV Nucleocapsid protein related to age in the mouse. (edit)
SARS-virus (edit) Differential inhibitory activities and stabilisation of DNA aptamers against the SARS coronavirus helicase (edit)
SARS-virus (edit) Differential stepwise evolution of SARS coronavirus functional proteins in different host species (edit)
SARS-virus (edit) Diffuse alveolar lesion in BALB/c mice induced with human reovirus BYD1 strain and its potential relation with SARS. (edit)
SARS-virus (edit) Direct sequencing of SARS-coronavirus S and N genes from clinical specimens shows limited variation. (edit)
SARS-virus (edit) Direct template matching reveals a host subcellular membrane gyroid cubic structure that is associated with SARS virus. (edit)
SARS-virus (edit) Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: Identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding (edit)
SARS-virus (edit) Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus. (edit)
SARS-virus (edit) Discovery of unsymmetrical aromatic disulfides as novel inhibitors of SARS-CoV main protease: Chemical synthesis, biological evaluation, molecular docking and 3D-QSAR study (edit)
SARS-virus (edit) Discovery, synthesis, and structure-based optimization of a series of N-(tert-butyl)-2-(N-arylamido)-2-(pyridin-3-yl) acetamides (ML188) as potent noncovalent small molecule inhibitors of the severe acute respiratory syndrome coronavirus (SARS-CoV) (edit)
SARS-virus (edit) Dissection of the fusion machine of SARS-coronavirus. (edit)
SARS-virus (edit) Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus (edit)
SARS-virus (edit) Domestic poultry and SARS coronavirus, southern China (edit)
SARS-virus (edit) Double-antigen sandwich ELISA for detection of antibodies to SARS-associated coronavirus in human serum. (edit)
SARS-virus (edit) Drug targets in severe acute respiratory syndrome (edit)
SARS-virus (edit) Dynamic changes of serum SARS-coronavirus IgG, pulmonary function and radiography in patients recovering from SARS after hospital discharge (edit)
SARS-virus (edit) Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice. (edit)
SARS-virus (edit) Early diagnosis of SARS coronavirus infection by real time RT-PCR. (edit)
SARS-virus (edit) Early events of SARS coronavirus infection in vero cells. (edit)
SARS-virus (edit) Early gene expression events in ferrets in response to SARS coronavirus infection versus direct interferon-alpha2b stimulation. (edit)
SARS-virus (edit) Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS. (edit)
SARS-virus (edit) Effects of a SARS-associated coronavirus vaccine in monkeys. (edit)
SARS-virus (edit) Effects of different immunization protocols and adjuvant on antibody responses to inactivated SARS-CoV vaccine. (edit)
SARS-virus (edit) Effects of severe acute respiratory syndrome (edit)
SARS-virus (edit) Efficacy of various disinfectants against SARS coronavirus. (edit)
SARS-virus (edit) Efficient and quick inactivation of SARS coronavirus and other microbes exposed to the surfaces of some metal catalysts. (edit)
SARS-virus (edit) Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system. (edit)
SARS-virus (edit) Efficient induction of cytotoxic T lymphocytes specific for severe acute respiratory syndrome (edit)
SARS-virus (edit) Elevated plasma surfactant protein D (edit)
SARS-virus (edit) Emergency medical services utilization during an outbreak of severe acute respiratory syndrome (edit)
SARS-virus (edit) Emodin inhibits current through SARS-associated coronavirus 3a protein (edit)
SARS-virus (edit) Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2. (edit)
SARS-virus (edit) Enhancement of SARS-CoV infection by proteases. (edit)
SARS-virus (edit) Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin. (edit)
SARS-virus (edit) Enhancing immune responses against SARS-CoV nucleocapsid DNA vaccine by co-inoculating interleukin-2 expressing vector in mice (edit)
SARS-virus (edit) Environmental and occupational health response to SARS, Taiwan, 2003. (edit)
SARS-virus (edit) Environmental transmission of SARS at Amoy Gardens. (edit)
SARS-virus (edit) Erratum to: Liberation of SARS-CoV main protease from the viral polyprotein: N-terminal autocleavage does not depend on the mature dimerization mode. (edit)
SARS-virus (edit) Essential covalent linkage between the chymotrypsin-like domain and the extra domain of the SARS-CoV main protease. (edit)
SARS-virus (edit) Establishment and characterization of monoclonal antibodies against SARS coronavirus. (edit)
SARS-virus (edit) Establishment of a fluorescent polymerase chain reaction method for the detection of the SARS-associated coronavirus and its clinical application. (edit)
SARS-virus (edit) Establishment of the eukaryotic cell lines for inducible control of SARS-CoV nucleocapsid gene expression (edit)
SARS-virus (edit) Evaluating the 3C-like protease activity of SARS-Coronavirus: recommendations for standardized assays for drug discovery. (edit)
SARS-virus (edit) Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine. (edit)
SARS-virus (edit) Evaluation of a novel vesicular stomatitis virus pseudotype-based assay for detection of neutralizing antibody responses to SARS-CoV. (edit)
SARS-virus (edit) Evaluation of a peptide-based enzyme immunoassay for anti-SARS coronavirus IgG antibody. (edit)
SARS-virus (edit) Evaluation of a real-time polymerase-chain reaction for severe acute respiratory syndrome (edit)
SARS-virus (edit) Evaluation of a recombinant nucleocapsid protein-based assay for anti-SARS-CoV IgG detection. (edit)
SARS-virus (edit) Evaluation of a safe and sensitive Spike protein-based immunofluorescence assay for the detection of antibody responses to SARS-CoV. (edit)
SARS-virus (edit) Evaluation of homology modeling of the severe acute respiratory syndrome (edit)
SARS-virus (edit) Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV. (edit)
SARS-virus (edit) Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets. (edit)
SARS-virus (edit) Evaluation of the safety, immunogenicity and pharmacokinetics of equine anti-SARS-CoV F(ab')(2) in macaque. (edit)
SARS-virus (edit) Evasion by stealth: inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice (edit)
SARS-virus (edit) Evidence from the evolutionary analysis of nucleotide sequences for a recombinant history of SARS-CoV. (edit)
SARS-virus (edit) Evidence of the recombinant origin of a bat severe acute respiratory syndrome (edit)
SARS-virus (edit) Evolution and variation of the SARS-CoV genome. (edit)
SARS-virus (edit) Evolutional insights on uncharacterized SARS coronavirus genes. (edit)
SARS-virus (edit) Excretion and detection of SARS coronavirus and its nucleic acid from digestive system (edit)
SARS-virus (edit) Exploring the pathogenesis of severe acute respiratory syndrome (SARS): the tissue distribution of the coronavirus (SARS-CoV) and its putative receptor, angiotensin-converting enzyme 2 (ACE2). (edit)
SARS-virus (edit) Expression and characterization of recombinant S2 subunit of SARS-coronavirus S fusion protein. (edit)
SARS-virus (edit) Expression and functional characterisation of the putative SARS coronavirus non-structural proteins X1-X5. (edit)
SARS-virus (edit) Expression and purification of SARS coronavirus membrane protein. (edit)
SARS-virus (edit) Expression and purification of SARS coronavirus proteins using SUMO-fusions. (edit)
SARS-virus (edit) Expression and renaturation of a novel human single-chain Fv antibody against SARS-CoV (edit)
SARS-virus (edit) Expression cloning of functional receptor used by SARS coronavirus (edit)
SARS-virus (edit) Expression of SARS-coronavirus envelope protein in Escherichia coli cells alters membrane permeability. (edit)
SARS-virus (edit) Expression of SARS-coronavirus nucleocapsid protein in Escherichia coli and Lactococcus lactis for serodiagnosis and mucosal vaccination. (edit)
SARS-virus (edit) Expression of SARS-coronavirus spike glycoprotein in Pichia pastoris. (edit)
SARS-virus (edit) Expression of feline angiotensin converting enzyme 2 and its interaction with SARS-CoV S1 protein. (edit)
SARS-virus (edit) Expression, crystallization and preliminary crystallographic study of the C-terminal half of nsp2 from SARS coronavirus (edit)
SARS-virus (edit) Expression, purification and crystallization of the SARS-CoV macro domain. (edit)
SARS-virus (edit) Expression, purification, and characterization of SARS coronavirus RNA polymerase. (edit)
SARS-virus (edit) Extraordinary GU-rich single-strand RNA identified from SARS coronavirus contributes an excessive innate immune response. (edit)
SARS-virus (edit) Ezrin interacts with the SARS coronavirus Spike protein and restrains infection at the entry stage (edit)
SARS-virus (edit) Factors associated with nosocomial SARS-CoV transmission among healthcare workers in Hanoi, Vietnam, 2003 (edit)
SARS-virus (edit) False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (edit)
SARS-virus (edit) False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid-based western blot assay were rectified by the use of two subunits (S1 and S2) of spike for detection of antibody to SARS-CoV. (edit)
SARS-virus (edit) First external quality assurance of antibody diagnostic for SARS-new coronavirus. (edit)
SARS-virus (edit) Folding of the SARS coronavirus spike glycoprotein immunological fragment (edit)
SARS-virus (edit) Formalin-treated UV-inactivated SARS coronavirus vaccine retains its immunogenicity and promotes Th2-type immune responses. (edit)
SARS-virus (edit) From SARS coronavirus to novel animal and human coronaviruses. (edit)
SARS-virus (edit) From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses (edit)
SARS-virus (edit) From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design (edit)
SARS-virus (edit) From genome to antivirals: SARS as a test tube. (edit)
SARS-virus (edit) From genome to drug lead: identification of a small-molecule inhibitor of the SARS virus. (edit)
SARS-virus (edit) Fully human monoclonal antibody directed to proteolytic cleavage site in severe acute respiratory syndrome (edit)
SARS-virus (edit) Fusion core structure of the severe acute respiratory syndrome coronavirus (edit)
SARS-virus (edit) Future antivirals-SMi conference: latest developments in HIV, hepatitis, herpes, influenza, RSV and SARS. (edit)
SARS-virus (edit) G0/G1 arrest and apoptosis induced by SARS-CoV 3b protein in transfected cells (edit)
SARS-virus (edit) Generating stable Chinese hamster ovary cell clones to produce a truncated SARS-CoV spike protein for vaccine development. (edit)
SARS-virus (edit) Generation of human antibody fragments recognizing distinct epitopes of the nucleocapsid (N) SARS-CoV protein using a phage display approach (edit)
SARS-virus (edit) Generation of predictive pharmacophore model for SARS-coronavirus main proteinase (edit)
SARS-virus (edit) Genetic variation of SARS coronavirus in Beijing Hospital (edit)
SARS-virus (edit) Genetic variation of the human α-2-Heremans-Schmid glycoprotein (edit)
SARS-virus (edit) Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative Cross (edit)
SARS-virus (edit) Genome organization of the SARS-CoV. (edit)
SARS-virus (edit) Genomic analysis and geographic visualization of H5N1 and SARS-CoV. (edit)
SARS-virus (edit) Genomic classification using an information-based similarity index: application to the SARS coronavirus. (edit)
SARS-virus (edit) Genosensor on gold films with enzymatic electrochemical detection of a SARS virus sequence. (edit)
SARS-virus (edit) Geranylated flavonoids displaying SARS-CoV papain-like protease inhibition from the fruits of Paulownia tomentosa. (edit)
SARS-virus (edit) Getting ready for SARS. Officials consider tough measures to contain outbreaks should deadly virus return. (edit)
SARS-virus (edit) Global virus alert. How SARS highlighted the risk of viral pandemics (edit)
SARS-virus (edit) Glycan arrays lead to the discovery of autoimmunogenic activity of SARS-CoV. (edit)
SARS-virus (edit) Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. (edit)
SARS-virus (edit) Growth kinetics of SARS-coronavirus in Vero E6 cells. (edit)
SARS-virus (edit) HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus. (edit)
SARS-virus (edit) HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins (edit)
SARS-virus (edit) Heat sensitivity of a SARS-associated coronavirus introduced into plasma products. (edit)
SARS-virus (edit) Heterologous MVA-S prime Ad5-S boost regimen induces high and persistent levels of neutralizing antibody response against SARS coronavirus. (edit)
SARS-virus (edit) Heterologous expression of SARS-CoV ORF10 and X5 genes in E. coli and Streptomyces lividans TK24. (edit)
SARS-virus (edit) High expression level of soluble SARS spike protein mediated by adenovirus in HEK293 cells (edit)
SARS-virus (edit) High-dose hydrocortisone reduces expression of the pro-inflammatory chemokines CXCL8 and CXCL10 in SARS coronavirus-infected intestinal cells (edit)
SARS-virus (edit) High-throughput assay using a GFP-expressing replicon for SARS-CoV drug discovery (edit)
SARS-virus (edit) High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase. (edit)
SARS-virus (edit) Highly attenuated vaccinia virus DIs as a potential SARS vaccine. (edit)
SARS-virus (edit) Homozygous L-SIGN (edit)
SARS-virus (edit) Hong Kong health chief falls ill with suspected SARS virus. (edit)
SARS-virus (edit) How the SARS coronavirus causes disease: host or organism? (edit)
SARS-virus (edit) Human CD4 (edit)
SARS-virus (edit) Human LINE1 endonuclease domain as a putative target of SARS-associated autoantibodies involved in the pathogenesis of severe acute respiratory syndrome (edit)
SARS-virus (edit) Human SARS-coronavirus RNA-dependent RNA polymerase: activity determinants and nucleoside analogue inhibitors. (edit)
SARS-virus (edit) Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines (edit)
SARS-virus (edit) Human memory T cell responses to SARS-CoV E protein. (edit)
SARS-virus (edit) Human metapneumovirus-associated atypical pneumonia and SARS. (edit)
SARS-virus (edit) Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing (edit)
SARS-virus (edit) Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets. (edit)
SARS-virus (edit) Human severe acute respiratory syndrome (edit)
SARS-virus (edit) Humoral and cellular immune responses induced by 3a DNA vaccines against severe acute respiratory syndrome (edit)
SARS-virus (edit) Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS-CoV vaccine. (edit)
SARS-virus (edit) Identification and characterization of three novel small interference RNAs that effectively down-regulate the isolated nucleocapsid gene expression of SARS coronavirus (edit)
SARS-virus (edit) Identification and molecular cloning and sequence analysis of a novel coronavirus from patients with SARS by RT-PCR (edit)
SARS-virus (edit) Identification of Essential Genes as a Strategy to Select a Sars Candidate Vaccine Using a SARS-CoV Infectious cDNA (edit)
SARS-virus (edit) Identification of a B-cell antigenic epitope at the N-terminus of SARS-CoV M protein and characterization of monoclonal antibody against the protein. (edit)
SARS-virus (edit) Identification of a new region of SARS-CoV S protein critical for viral entry. (edit)
SARS-virus (edit) Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV. (edit)
SARS-virus (edit) Identification of a novel transcriptional repressor (edit)
SARS-virus (edit) Identification of an epitope of SARS-coronavirus nucleocapsid protein. (edit)
SARS-virus (edit) Identification of effective siRNA blocking the expression of SARS viral envelope E and RDRP genes. (edit)
SARS-virus (edit) Identification of ferret ACE2 and its receptor function for SARS-coronavirus. (edit)
SARS-virus (edit) Identification of human cell line model of persistent SARS coronavirus infection and studies of the response to cytokines and chemokines. (edit)
SARS-virus (edit) Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (edit)
SARS-virus (edit) Identification of immunogenic determinants of the spike protein of SARS-like coronavirus (edit)
SARS-virus (edit) Identification of mimotope peptides which bind to the SARS-CoV spike protein specific monoclonal antibody 2C5 with phage-displayed peptides library (edit)
SARS-virus (edit) Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13. (edit)
SARS-virus (edit) Identification of natural compounds with antiviral activities against SARS-associated coronavirus (edit)
SARS-virus (edit) Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual and high-throughput screenings (edit)
SARS-virus (edit) Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro. (edit)
SARS-virus (edit) Identification of probable genomic packaging signal sequence from SARS-CoV genome by bioinformatics analysis (edit)
SARS-virus (edit) Identification of pulmonary Oct-4+ stem/progenitor cells and demonstration of their susceptibility to SARS coronavirus (edit)
SARS-virus (edit) Identification of single-chain antibody fragments specific against SARS-associated coronavirus from phage-displayed antibody library (edit)
SARS-virus (edit) Identification of the Mechanisms Causing Reversion to Virulence in an Attenuated SARS-CoV for the Design of a Genetically Stable Vaccine. (edit)
SARS-virus (edit) Identification of two antigenic epitopes on SARS-CoV spike protein. (edit)
SARS-virus (edit) Identifying a killer: SARS virus. (edit)
SARS-virus (edit) Identifying inhibitors of the SARS coronavirus proteinase. (edit)
SARS-virus (edit) Immune responses in Balb/c mice induced by a candidate SARS-CoV inactivated vaccine prepared from F69 strain. (edit)
SARS-virus (edit) Immune responses to T-cell epitopes of SARS CoV-N protein are enhanced by N immunization with a chimera of lysosome-associated membrane protein. (edit)
SARS-virus (edit) Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus (edit)
SARS-virus (edit) Immunization with SARS-CoV S DNA vaccine generates memory CD4+ and CD8+ T cell immune responses. (edit)
SARS-virus (edit) Immunofluorescence assay for detection of the nucleocapsid antigen of the severe acute respiratory syndrome (SARS)-associated coronavirus in cells derived from throat wash samples of patients with SARS. (edit)
SARS-virus (edit) Immunogenicity and protection efficacy of monomeric and trimeric recombinant SARS coronavirus spike protein subunit vaccine candidates (edit)
SARS-virus (edit) Immunogenicity and protective efficacy in mice and hamsters of a β-propiolactone inactivated whole virus SARS-CoV vaccine (edit)
SARS-virus (edit) Immunogenicity difference between the SARS coronavirus and the bat SARS-like coronavirus spike (edit)
SARS-virus (edit) Immunogenicity of a receptor-binding domain of SARS coronavirus spike protein in mice: implications for a subunit vaccine (edit)
SARS-virus (edit) Immunogenicity, safety, and protective efficacy of an inactivated SARS-associated coronavirus vaccine in rhesus monkeys. (edit)
SARS-virus (edit) Immunological responses against SARS-coronavirus infection in humans. (edit)
SARS-virus (edit) Immunological, structural, and preliminary X-ray diffraction characterizations of the fusion core of the SARS-coronavirus spike protein. (edit)
SARS-virus (edit) Immunopathogenesis of coronavirus infections: implications for SARS. (edit)
SARS-virus (edit) Importance of Akt signaling pathway for apoptosis in SARS-CoV-infected Vero E6 cells. (edit)
SARS-virus (edit) Importance of SARS-CoV spike protein Trp-rich region in viral infectivity. (edit)
SARS-virus (edit) Improved prediction of MHC class I binders/non-binders peptides through artificial neural network using variable learning rate: SARS corona virus, a case study. (edit)
SARS-virus (edit) In Vitro Antiviral Activity of some Novel Isatin Derivatives against HCV and SARS-CoV Viruses (edit)
SARS-virus (edit) In silico prediction of SARS protease inhibitors by virtual high throughput screening. (edit)
SARS-virus (edit) In vitro anti-hepatitis B and SARS virus activities of a titanium-substituted-heteropolytungstate. (edit)
SARS-virus (edit) In vitro biochemical and thermodynamic characterization of nucleocapsid protein of SARS. (edit)
SARS-virus (edit) Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry. (edit)
SARS-virus (edit) Inactivated SARS-CoV vaccine prepared from whole virus induces a high level of neutralizing antibodies in BALB/c mice. (edit)
SARS-virus (edit) Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents. (edit)
SARS-virus (edit) Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions, and chemical reagents. (edit)
SARS-virus (edit) Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV. (edit)
SARS-virus (edit) Increase of SARS-CoV 3CL peptidase activity due to macromolecular crowding effects in the milieu composition. (edit)
SARS-virus (edit) Indomethacin has a potent antiviral activity against SARS coronavirus (edit)
SARS-virus (edit) Induction of Th1 type response by DNA vaccinations with N, M, and E genes against SARS-CoV in mice. (edit)
SARS-virus (edit) Induction of interferon-gamma-inducible protein 10 by SARS-CoV infection, interferon alfacon 1 and interferon inducer in human bronchial epithelial Calu-3 cells and BALB/c mice. (edit)
SARS-virus (edit) Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses. (edit)
SARS-virus (edit) Infection of human airway epithelia by SARS coronavirus is associated with ACE2 expression and localization (edit)
SARS-virus (edit) Infectious diseases. One year after outbreak, SARS virus yields some secrets. (edit)
SARS-virus (edit) Influence of HLA gene polymorphisms on susceptibility and outcome post infection with the SARS-CoV virus. (edit)
SARS-virus (edit) Influence of hydrophobic and electrostatic residues on SARS-coronavirus S2 protein stability: insights into mechanisms of general viral fusion and inhibitor design (edit)
SARS-virus (edit) Influence of intron and exon splicing enhancers on mammalian cell expression of a truncated spike protein of SARS-CoV and its implication for subunit vaccine development. (edit)
SARS-virus (edit) Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts (edit)
SARS-virus (edit) Influenza and SARS: the impact of viral pandemics on maritime health. (edit)
SARS-virus (edit) Influenza as a model system for studying the cross-species transfer and evolution of the SARS coronavirus. (edit)
SARS-virus (edit) Inhibition of SARS coronavirus helicase by bismuth complexes. (edit)
SARS-virus (edit) Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs (edit)
SARS-virus (edit) Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans (edit)
SARS-virus (edit) Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3'-digallate (TF3) (edit)
SARS-virus (edit) Inhibition of SARS-CoV replication by siRNA. (edit)
SARS-virus (edit) Inhibition of SARS-CoV replication cycle by small interference RNAs silencing specific SARS proteins, 7a/7b, 3a/3b and S. (edit)
SARS-virus (edit) Inhibition of SARS-associated coronavirus infection and replication by RNA interference. (edit)
SARS-virus (edit) Inhibition of SARS-coronavirus infection in vitro by S-nitroso-N-acetylpenicillamine, a nitric oxide donor compound. (edit)
SARS-virus (edit) Inhibition of cell proliferation by SARS-CoV infection in Vero E6 cells. (edit)
SARS-virus (edit) Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs. (edit)
SARS-virus (edit) Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin (edit)
SARS-virus (edit) Inhibition of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) infectivity by peptides analogous to the viral spike protein (edit)
SARS-virus (edit) Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies. (edit)
SARS-virus (edit) Inhibitor design for SARS coronavirus main protease based on "distorted key theory". (edit)
SARS-virus (edit) Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV (edit)
SARS-virus (edit) Inhibitors of SARS-3CLpro: virtual screening, biological evaluation, and molecular dynamics simulation studies (edit)
SARS-virus (edit) Inhibitors of SARS-CoV entry--identification using an internally-controlled dual envelope pseudovirion assay (edit)
SARS-virus (edit) Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (edit)
SARS-virus (edit) Initial viral load and the outcomes of SARS. (edit)
SARS-virus (edit) Insights from the association of SARS-CoV S-protein with its receptor, ACE2. (edit)
SARS-virus (edit) Insurance and epidemics: SARS, West Nile virus and Nipah virus. (edit)
SARS-virus (edit) Interaction between SARS-CoV helicase and a multifunctional cellular protein (Ddx5) revealed by yeast and mammalian cell two-hybrid systems (edit)
SARS-virus (edit) Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors. (edit)
SARS-virus (edit) Interaction of SARS and MERS Coronaviruses with the Antiviral Interferon Response. (edit)
SARS-virus (edit) Interaction of a peptide corresponding to the loop domain of the S2 SARS-CoV virus protein with model membranes. (edit)
SARS-virus (edit) Interactions among SARS-CoV accessory proteins revealed by bimolecular fluorescence complementation assay. (edit)
SARS-virus (edit) Interferon alfacon 1 inhibits SARS-CoV infection in human bronchial epithelial Calu-3 cells (edit)
SARS-virus (edit) Interferon alfacon1 is an inhibitor of SARS-corona virus in cell-based models. (edit)
SARS-virus (edit) Interferon and cytokine responses to SARS-coronavirus infection (edit)
SARS-virus (edit) Interferon interplay helps tissue cells to cope with SARS-coronavirus infection (edit)
SARS-virus (edit) Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation (edit)
SARS-virus (edit) Interferon-beta 1a and SARS coronavirus replication (edit)
SARS-virus (edit) Interferon-gamma and interleukin-4 downregulate expression of the SARS coronavirus receptor ACE2 in Vero E6 cells. (edit)
SARS-virus (edit) Intranasal immunization with inactivated SARS-CoV (edit)
SARS-virus (edit) Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus/polyethylenimine nanoparticles elicits antigen-specific humoral and cellular immune responses. (edit)
SARS-virus (edit) Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (edit)
SARS-virus (edit) Intraspecies diversity of SARS-like coronaviruses in Rhinolophus sinicus and its implications for the origin of SARS coronaviruses in humans. (edit)
SARS-virus (edit) Investigation of immunogenic T-cell epitopes in SARS virus nucleocapsid protein and their role in the prevention and treatment of SARS infection. (edit)
SARS-virus (edit) Investigation of interaction between two neutralizing monoclonal antibodies and SARS virus using biosensor based on imaging ellipsometry. (edit)
SARS-virus (edit) Investigation of interactions between two monoclonal antibodies and SARS virus with a Label-free Protein Array. (edit)
SARS-virus (edit) Investigation of the pharmacophore space of Severe Acute Respiratory Syndrome coronavirus (edit)
SARS-virus (edit) Is serum in childhood naturally protective against SARS-coronavirus? (edit)
SARS-virus (edit) Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections? Lack of efficacy of promazine on SARS-CoV replication in a mouse model (edit)
SARS-virus (edit) Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic? (edit)
SARS-virus (edit) Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor (edit)
SARS-virus (edit) Isolation and identification of an scFv antibody against nucleocapsid protein of SARS-CoV. (edit)
SARS-virus (edit) Isolation of inhibitory RNA aptamers against severe acute respiratory syndrome (edit)
SARS-virus (edit) JNK and PI3k/Akt signaling pathways are required for establishing persistent SARS-CoV infection in Vero E6 cells. (edit)
SARS-virus (edit) Label-free, electrical detection of the SARS virus N-protein with nanowire biosensors utilizing antibody mimics as capture probes. (edit)
SARS-virus (edit) Laboratory containment of SARS virus. (edit)
SARS-virus (edit) Lack of association between HLA-A, -B and -DRB1 alleles and the development of SARS: a cohort of 95 SARS-recovered individuals in a population of Guangdong, southern China. (edit)
SARS-virus (edit) Lack of association between polymorphisms of MASP2 and susceptibility to SARS coronavirus infection (edit)
SARS-virus (edit) Lack of innate interferon responses during SARS coronavirus infection in a vaccination and reinfection ferret model (edit)
SARS-virus (edit) Lessons learned from SARS outbreak prompt rapid response to new coronavirus. (edit)
SARS-virus (edit) Lipid rafts are involved in SARS-CoV entry into Vero E6 cells (edit)
SARS-virus (edit) Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (edit)
SARS-virus (edit) Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients. (edit)
SARS-virus (edit) Long-term SARS coronavirus excretion from patient cohort, China (edit)
SARS-virus (edit) Long-term persistence of robust antibody and cytotoxic T cell responses in recovered patients infected with SARS coronavirus. (edit)
SARS-virus (edit) Longitudinal analysis of Severe Acute Respiratory Syndrome (SARS) coronavirus-specific antibody in SARS patients (edit)
SARS-virus (edit) Longitudinal profile of antibodies against SARS-coronavirus in SARS patients and their clinical significance. (edit)
SARS-virus (edit) Longitudinal surveillance of SARS-like coronaviruses in bats by quantitative real-time PCR. (edit)
SARS-virus (edit) Longitudinally profiling neutralizing antibody response to SARS coronavirus with pseudotypes (edit)
SARS-virus (edit) MERS, SARS and other coronaviruses as causes of pneumonia. (edit)
SARS-virus (edit) Mapping a neutralizing epitope on the SARS coronavirus spike protein: computational prediction based on affinity-selected peptides. (edit)
SARS-virus (edit) Mass spectrometric characterization of proteins from the SARS virus: a preliminary report (edit)
SARS-virus (edit) Mechanism for controlling the monomer-dimer conversion of SARS coronavirus main protease (edit)
SARS-virus (edit) Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (edit)
SARS-virus (edit) Medical treatment of viral pneumonia including SARS in immunocompetent adult (edit)
SARS-virus (edit) Medusa's ugly head again: from SARS to MERS-CoV. (edit)
SARS-virus (edit) Mice susceptible to SARS coronavirus (edit)
SARS-virus (edit) Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection. (edit)
SARS-virus (edit) Microarray and real-time RT-PCR analyses of differential human gene expression patterns induced by severe acute respiratory syndrome (edit)
SARS-virus (edit) Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease (edit)
SARS-virus (edit) Middle East respiratory syndrome: SARS redux? (edit)
SARS-virus (edit) Mining SARS-CoV protease cleavage data using non-orthogonal decision trees: a novel method for decisive template selection (edit)
SARS-virus (edit) Moderate mutation rate in the SARS coronavirus genome and its implications (edit)
SARS-virus (edit) Modification of SARS-CoV S1 gene render expression in Pichia pastoris. (edit)
SARS-virus (edit) Molecular advances in severe acute respiratory syndrome-associated coronavirus (SARS-CoV). (edit)
SARS-virus (edit) Molecular advances in the cell biology of SARS-CoV and current disease prevention strategies (edit)
SARS-virus (edit) Molecular characterization of a panel of murine monoclonal antibodies specific for the SARS-coronavirus. (edit)
SARS-virus (edit) Molecular cloning, expression, and purification of SARS-CoV nsp13. (edit)
SARS-virus (edit) Molecular cloning, expression, purification, and mass spectrometric characterization of 3C-like protease of SARS coronavirus. (edit)
SARS-virus (edit) Molecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV Mpro. (edit)
SARS-virus (edit) Molecular dynamic simulations analysis of ritonavir and lopinavir as SARS-CoV 3CL (edit)
SARS-virus (edit) Molecular epidemiology of SARS-associated coronavirus, Beijing (edit)
SARS-virus (edit) Molecular evolution and multilocus sequence typing of 145 strains of SARS-CoV. (edit)
SARS-virus (edit) Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. (edit)
SARS-virus (edit) Molecular modelling of S1 and S2 subunits of SARS coronavirus spike glycoprotein. (edit)
SARS-virus (edit) Molecular signature of clinical severity in recovering patients with severe acute respiratory syndrome coronavirus (SARS-CoV) (edit)
SARS-virus (edit) Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (edit)
SARS-virus (edit) Monoclonal antibodies to SARS-associated coronavirus (SARS-CoV): identification of neutralizing and antibodies reactive to S, N, M and E viral proteins (edit)
SARS-virus (edit) Morphology and morphogenesis of severe acute respiratory syndrome (edit)
SARS-virus (edit) Mouse studies of SARS coronavirus-specific immune responses to recombinant replication-defective adenovirus expressing SARS coronavirus N protein. (edit)
SARS-virus (edit) Mucosal immunisation of African green monkeys (edit)
SARS-virus (edit) Multi-organ lesions in suckling mice infected with SARS-associated mammalian reovirus linked with apoptosis induced by viral proteins μ1 and σ1 (edit)
SARS-virus (edit) Multi-zone modeling of probable SARS virus transmission by airflow between flats in Block E, Amoy Gardens. (edit)
SARS-virus (edit) Murine hepatitis virus strain 1 as a model for severe acute respiratory distress syndrome (edit)
SARS-virus (edit) Mutagenesis of the transmembrane domain of the SARS coronavirus spike glycoprotein: refinement of the requirements for SARS coronavirus cell entry (edit)
SARS-virus (edit) Mutational and inhibitive analysis of SARS coronavirus 3C-like protease by fluorescence resonance energy transfer-based assays. (edit)
SARS-virus (edit) Mutational dynamics of the SARS coronavirus in cell culture and human populations isolated in 2003 (edit)
SARS-virus (edit) Mutational patterns correlate with genome organization in SARS and other coronaviruses (edit)
SARS-virus (edit) MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV. (edit)
SARS-virus (edit) NMR assignment of the protein nsp3a from SARS-CoV. (edit)
SARS-virus (edit) Neutralizing antibody against severe acute respiratory syndrome (edit)
SARS-virus (edit) Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein (edit)
SARS-virus (edit) Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology (edit)
SARS-virus (edit) New Frameshifting Pseudoknot Found in SARS Virus (edit)
SARS-virus (edit) New antiviral drugs, vaccines and classic public health interventions against SARS coronavirus (edit)
SARS-virus (edit) New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CL(pro) inhibitors (edit)
SARS-virus (edit) Novel SARS-like betacoronaviruses in bats, China, 2011. (edit)
SARS-virus (edit) Novel rapid immunochromatographic test based on an enzyme immunoassay for detecting nucleocapsid antigen in SARS-associated coronavirus. (edit)
SARS-virus (edit) Novel system for detecting SARS coronavirus nucleocapsid protein using an ssDNA aptamer (edit)
SARS-virus (edit) Object-oriented biological system integration: a SARS coronavirus example. (edit)
SARS-virus (edit) Old drugs as lead compounds for a new disease? Binding analysis of SARS coronavirus main proteinase with HIV, psychotic and parasite drugs. (edit)
SARS-virus (edit) One-tube nested RT-PCR enabled by using a plastic film and its application for the rapid detection of SARS-virus. (edit)
SARS-virus (edit) Optimization of the Production Process and Characterization of the Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1), a SARS Vaccine Candidate (edit)
SARS-virus (edit) Organ distribution of severe acute respiratory syndrome (edit)
SARS-virus (edit) Osteonecrosis in patients after severe acute respiratory syndrome (edit)
SARS-virus (edit) PIKA provides an adjuvant effect to induce strong mucosal and systemic humoral immunity against SARS-CoV. (edit)
SARS-virus (edit) Palindromes in SARS and Other Coronaviruses (edit)
SARS-virus (edit) Palmitoylation of SARS-CoV S protein is necessary for partitioning into detergent-resistant membranes and cell-cell fusion but not interaction with M protein (edit)
SARS-virus (edit) Palmitoylation of the cysteine-rich endodomain of the SARS-coronavirus spike glycoprotein is important for spike-mediated cell fusion. (edit)
SARS-virus (edit) Papain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): expression, purification, characterization, and inhibition. (edit)
SARS-virus (edit) Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 rats infected with SARS coronavirus (edit)
SARS-virus (edit) Pathogenesis of SARS coronavirus infection using human lung epithelial cells: an in vitro model. (edit)
SARS-virus (edit) Pathology of experimental SARS coronavirus infection in cats and ferrets. (edit)
SARS-virus (edit) Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques. (edit)
SARS-virus (edit) Peptide domain involved in the interaction between membrane protein and nucleocapsid protein of SARS-associated coronavirus. (edit)
SARS-virus (edit) Peptide mimicrying between SARS coronavirus spike protein and human proteins reacts with SARS patient serum (edit)
SARS-virus (edit) Peptides derived from HIV-1, HIV-2, Ebola virus, SARS coronavirus and coronavirus 229E exhibit high affinity binding to the formyl peptide receptor (edit)
SARS-virus (edit) Peptides from the SARS-associated coronavirus as tags for protein expression and purification. (edit)
SARS-virus (edit) Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen (edit)
SARS-virus (edit) Persistent shedding of viable SARS-CoV in urine and stool of SARS patients during the convalescent phase. (edit)
SARS-virus (edit) Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirus (edit)
SARS-virus (edit) Phylogenetic analysis and sequence comparisons of structural and non-structural SARS coronavirus proteins in Taiwan. (edit)
SARS-virus (edit) Phylogenetic analysis of the full-length SARS-CoV sequences: evidence for phylogenetic discordance in three genomic regions. (edit)
SARS-virus (edit) Phylogenetic perspectives on the epidemiology and origins of SARS and SARS-like coronaviruses (edit)
SARS-virus (edit) Phylogenomics and bioinformatics of SARS-CoV. (edit)
SARS-virus (edit) Phylogeny of the SARS coronavirus. (edit)
SARS-virus (edit) Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells. (edit)
SARS-virus (edit) Piezoelectric immunosensor for SARS-associated coronavirus in sputum. (edit)
SARS-virus (edit) Polymorphism of SARS-CoV genomes. (edit)
SARS-virus (edit) Polyprotein cleavage mechanism of SARS CoV Mpro and chemical modification of the octapeptide. (edit)
SARS-virus (edit) Possible SARS coronavirus transmission during cardiopulmonary resuscitation. (edit)
SARS-virus (edit) Possible central nervous system infection by SARS coronavirus (edit)
SARS-virus (edit) Potent and persistent antibody responses against the receptor-binding domain of SARS-CoV spike protein in recovered patients (edit)
SARS-virus (edit) Potent and specific inhibition of SARS-CoV antigen expression by RNA interference (edit)
SARS-virus (edit) Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies (edit)
SARS-virus (edit) Potent in vitro activity of the albumin fusion type 1 interferons (edit)
SARS-virus (edit) Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association (edit)
SARS-virus (edit) Potential antivirals and antiviral strategies against SARS coronavirus infections (edit)
SARS-virus (edit) Potential cross-reactivity of severe acute respiratory syndrome-associated coronavirus (edit)
SARS-virus (edit) Potential for receptor-based antiviral drugs against SARS. (edit)
SARS-virus (edit) Potential targets for anti-SARS drugs in the structural proteins from SARS related coronavirus. (edit)
SARS-virus (edit) Prediction of amino acid pairs sensitive to mutations in the spike protein from SARS related coronavirus. (edit)
SARS-virus (edit) Prediction of functional class of the SARS coronavirus proteins by a statistical learning method. (edit)
SARS-virus (edit) Prediction of proteinase cleavage sites in polyproteins of coronaviruses and its applications in analyzing SARS-CoV genomes. (edit)
SARS-virus (edit) Prediction of quaternary assembly of SARS coronavirus peplomer. (edit)
SARS-virus (edit) Preliminary study on the detection of the SARS-CoV specific target cDNA fragments by multiplex PCR. (edit)
SARS-virus (edit) Prevalence of IgG antibody to SARS-associated coronavirus in animal traders--Guangdong Province, China, 2003. (edit)
SARS-virus (edit) Prevalence of SARS-CoV antibody in all Hong Kong patient contacts. (edit)
SARS-virus (edit) Prevalence of non-pneumonic infections with SARS-correlated virus. (edit)
SARS-virus (edit) Prevalence of subclinical infection by the SARS coronavirus among general practitioners in Hong Kong. (edit)
SARS-virus (edit) Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection. (edit)
SARS-virus (edit) Prior immunization with severe acute respiratory syndrome (edit)
SARS-virus (edit) Probing the structure of the SARS coronavirus using scanning electron microscopy (edit)
SARS-virus (edit) Procyanidins and butanol extract of Cinnamomi Cortex inhibit SARS-CoV infection. (edit)
SARS-virus (edit) Production of an anti-severe acute respiratory syndrome (SARS) coronavirus human monoclonal antibody Fab fragment by using a combinatorial immunoglobulin gene library derived from patients who recovered from SARS. (edit)
SARS-virus (edit) Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43. (edit)
SARS-virus (edit) Profile of specific antibodies to the SARS-associated coronavirus. (edit)
SARS-virus (edit) Profiles of IgG antibodies to nucleocapsid and spike proteins of the SARS-associated coronavirus in SARS patients. (edit)
SARS-virus (edit) Programmed ribosomal frameshifting in HIV-1 and the SARS-CoV. (edit)
SARS-virus (edit) Programmed ribosomal frameshifting in decoding the SARS-CoV genome (edit)
SARS-virus (edit) Progress in Anti-SARS Coronavirus Chemistry, Biology and Chemotherapy. (edit)
SARS-virus (edit) Prokaryotic expression of S2 extracellular domain of SARS coronavirus spike protein and its fusion with Hela cell membrane (edit)
SARS-virus (edit) Prokaryotic expression, refolding, and purification of fragment 450-650 of the spike protein of SARS-coronavirus. (edit)
SARS-virus (edit) Properties of isonucleotide-incorporated oligodeoxynucleotides and inhibition of the expression of spike protein of SARS-CoV. (edit)
SARS-virus (edit) Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol® (Poly IC:LC), in a lethal SARS-CoV-infected BALB/c mouse model (edit)
SARS-virus (edit) Proposal for vaccination against SARS coronavirus using avian infectious bronchitis virus strain H from The Netherlands. (edit)
SARS-virus (edit) Protein transfer enhances cellular immune responses to DNA vaccination against SARS-CoV. (edit)
SARS-virus (edit) Proteomic analysis of SARS associated coronavirus using two-dimensional liquid chromatography mass spectrometry and one-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis followed by mass spectroemtric analysis. (edit)
SARS-virus (edit) Pseudotyped vesicular stomatitis virus for analysis of virus entry mediated by SARS coronavirus spike proteins. (edit)
SARS-virus (edit) Pulmonary pathological features in coronavirus associated severe acute respiratory syndrome (SARS). (edit)
SARS-virus (edit) Putative hAPN receptor binding sites in SARS_CoV spike protein. (edit)
SARS-virus (edit) Pyridine N-oxide derivatives are inhibitory to the human SARS and feline infectious peritonitis coronavirus in cell culture. (edit)
SARS-virus (edit) Quantitative analysis of severe acute respiratory syndrome (edit)
SARS-virus (edit) Quantitative and sensitive detection of the SARS-CoV spike protein using bispecific monoclonal antibody-based enzyme-linked immunoassay (edit)
SARS-virus (edit) Quantitative temporal-spatial distribution of severe acute respiratory syndrome-associated coronavirus (edit)
SARS-virus (edit) Questions about comparative genomics of SARS coronavirus isolates. (edit)
SARS-virus (edit) RNA aptamer-based sensitive detection of SARS coronavirus nucleocapsid protein. (edit)
SARS-virus (edit) RNA dimerization plays a role in ribosomal frameshifting of the SARS coronavirus. (edit)
SARS-virus (edit) Rapid and sensitive detection of multiple genes from the SARS-coronavirus using quantitative RT-PCR with dual systems. (edit)
SARS-virus (edit) Rapid detection of the severe acute respiratory syndrome (edit)
SARS-virus (edit) Rapid diagnosis of a coronavirus associated with severe acute respiratory syndrome (edit)
SARS-virus (edit) Rapid peptide-based screening on the substrate specificity of severe acute respiratory syndrome (SARS) coronavirus 3C-like protease by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (edit)
SARS-virus (edit) Real-time NASBA detection of SARS-associated coronavirus and comparison with real-time reverse transcription-PCR (edit)
SARS-virus (edit) Real-time polymerase chain reaction for detecting SARS coronavirus, Beijing, 2003 (edit)
SARS-virus (edit) Real-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus (edit)
SARS-virus (edit) Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. (edit)
SARS-virus (edit) Receptor recognition and cross-species infections of SARS coronavirus (edit)
SARS-virus (edit) Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity (edit)
SARS-virus (edit) Reconstitution of the receptor-binding motif of the SARS coronavirus (edit)
SARS-virus (edit) Reduced incorporation of SARS-CoV spike protein into viral particles due to amino acid substitutions within the receptor binding domain. (edit)
SARS-virus (edit) Reference gene selection for quantitative real-time PCR analysis in virus infected cells: SARS corona virus, Yellow fever virus, Human Herpesvirus-6, Camelpox virus and Cytomegalovirus infections (edit)
SARS-virus (edit) Regulation of p90RSK phosphorylation by SARS-CoV infection in Vero E6 cells. (edit)
SARS-virus (edit) Relationship of SARS-CoV to other pathogenic RNA viruses explored by tetranucleotide usage profiling (edit)
SARS-virus (edit) Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia. (edit)
SARS-virus (edit) Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys. (edit)
SARS-virus (edit) Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506. (edit)
SARS-virus (edit) Residue analysis of a CTL epitope of SARS-CoV spike protein by IFN-gamma production and bioinformatics prediction (edit)
SARS-virus (edit) Response of memory CD8+ T cells to severe acute respiratory syndrome (edit)
SARS-virus (edit) Reverse genetics of SARS-related coronavirus using vaccinia virus-based recombination (edit)
SARS-virus (edit) Ribavirin for SARS in children. (edit)
SARS-virus (edit) Ribavirin in the treatment of SARS: A new trick for an old drug? (edit)
SARS-virus (edit) Ribavirin in the treatment of severe acute respiratory syndrome (SARS). (edit)
SARS-virus (edit) Risks to healthcare workers with emerging diseases: lessons from MERS-CoV, Ebola, SARS, and avian flu. (edit)
SARS-virus (edit) Roles of spike protein in the pathogenesis of SARS coronavirus. (edit)
SARS-virus (edit) Routes of transmission of influenza A H1N1, SARS CoV, and norovirus in air cabin: Comparative analyses. (edit)
SARS-virus (edit) SARS CoV replication and pathogenesis in human airway epithelial cultures. (edit)
SARS-virus (edit) SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement (edit)
SARS-virus (edit) SARS Coronavirus Fusion Peptide-Derived Sequence Suppresses Collagen-Induced Arthritis in DBA/1J Mice (edit)
SARS-virus (edit) SARS Coronaviruses and Highly Pathogenic Influenza Viruses: Safety and Occupational Health for Laboratory Workers. (edit)
SARS-virus (edit) SARS and MERS: recent insights into emerging coronaviruses (edit)
SARS-virus (edit) SARS and common viral infections (edit)
SARS-virus (edit) SARS and other coronaviruses in humans and animals (edit)
SARS-virus (edit) SARS associated coronavirus has a recombinant polymerase and coronaviruses have a history of host-shifting (edit)
SARS-virus (edit) SARS corona virus peptides recognized by antibodies in the sera of convalescent cases. (edit)
SARS-virus (edit) SARS coronavirus 8b reduces viral replication by down-regulating E via an ubiquitin-independent proteasome pathway. (edit)
SARS-virus (edit) SARS coronavirus and apoptosis. (edit)
SARS-virus (edit) SARS coronavirus and innate immunity (edit)
SARS-virus (edit) SARS coronavirus anti-infectives (edit)
SARS-virus (edit) SARS coronavirus detection methods. (edit)
SARS-virus (edit) SARS coronavirus detection. (edit)
SARS-virus (edit) SARS coronavirus nucleocapsid protein monoclonal antibodies developed using a prokaryotic expressed protein. (edit)
SARS-virus (edit) SARS coronavirus papain-like protease induces Egr-1-dependent up-regulation of TGF-β1 via ROS/p38 MAPK/STAT3 pathway (edit)
SARS-virus (edit) SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon (edit)
SARS-virus (edit) SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus. (edit)
SARS-virus (edit) SARS coronavirus without reservoir originated from an unnatural evolution, experienced the reverse evolution, and finally disappeared in the world (edit)
SARS-virus (edit) SARS coronavirus: a new challenge for prevention and therapy (edit)
SARS-virus (edit) SARS diagnosis, monitoring and prognostication by SARS-coronavirus RNA detection. (edit)
SARS-virus (edit) SARS genome chip available to scientists: the NIAID hopes that widespread access to the SARS genome chip will catalyse research into effective treatments for the virus. (edit)
SARS-virus (edit) SARS patients-derived human recombinant antibodies to S and M proteins efficiently neutralize SARS-coronavirus infectivity. (edit)
SARS-virus (edit) SARS transmission pattern in Singapore reassessed by viral sequence variation analysis (edit)
SARS-virus (edit) SARS vaccine based on a replication-defective recombinant vesicular stomatitis virus is more potent than one based on a replication-competent vector. (edit)
SARS-virus (edit) SARS veterans tackle coronavirus. (edit)
SARS-virus (edit) SARS viral RNA. (edit)
SARS-virus (edit) SARS virus identified, but the disease is still spreading. (edit)
SARS-virus (edit) SARS virus in tears? (edit)
SARS-virus (edit) SARS virus returns to China as scientists race to find effective vaccine. (edit)
SARS-virus (edit) SARS virus: the beginning of the unraveling of a new coronavirus (edit)
SARS-virus (edit) SARS--beginning to understand a new virus (edit)
SARS-virus (edit) SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii (edit)
SARS-virus (edit) SARS-CoV ORF1b-encoded nonstructural proteins 12-16: replicative enzymes as antiviral targets. (edit)
SARS-virus (edit) SARS-CoV and emergent coronaviruses: viral determinants of interspecies transmission (edit)
SARS-virus (edit) SARS-CoV antibody prevalence in all Hong Kong patient contacts (edit)
SARS-virus (edit) SARS-CoV genome polymorphism: a bioinformatics study. (edit)
SARS-virus (edit) SARS-CoV heptad repeat 2 is a trimer of parallel helices. (edit)
SARS-virus (edit) SARS-CoV infection in a restaurant from palm civet (edit)
SARS-virus (edit) SARS-CoV infection was from at least two origins in the Taiwan area. (edit)
SARS-virus (edit) SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism (edit)
SARS-virus (edit) SARS-CoV protease inhibitors design using virtual screening method from natural products libraries (edit)
SARS-virus (edit) SARS-CoV regulates immune function-related gene expression in human monocytic cells. (edit)
SARS-virus (edit) SARS-CoV related Betacoronavirus and diverse Alphacoronavirus members found in western old-world. (edit)
SARS-virus (edit) SARS-CoV replicates in primary human alveolar type II cell cultures but not in type I-like cells (edit)
SARS-virus (edit) SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epithelium (edit)
SARS-virus (edit) SARS-CoV sampling from 3 portals. (edit)
SARS-virus (edit) SARS-CoV spike protein-expressing recombinant vaccinia virus efficiently induces neutralizing antibodies in rabbits pre-immunized with vaccinia virus. (edit)
SARS-virus (edit) SARS-CoV spike proteins expressed by the vaccinia virus Tiantan strain: secreted sq protein induces robust neutralization antibody in mice. (edit)
SARS-virus (edit) SARS-CoV virus-host interactions and comparative etiologies of acute respiratory distress syndrome as determined by transcriptional and cytokine profiling of formalin-fixed paraffin-embedded tissues (edit)
SARS-virus (edit) SARS-CoV-Encoded Small RNAs Contribute to Infection-Associated Lung Pathology (edit)
SARS-virus (edit) SARS-CoV: Lessons for global health (edit)
SARS-virus (edit) SARS-Coronavirus ancestor's foot-prints in South-East Asian bat colonies and the refuge theory (edit)
SARS-virus (edit) SARS-associated coronavirus infection in teenagers. (edit)
SARS-virus (edit) SARS-associated coronavirus quasispecies in individual patients. (edit)
SARS-virus (edit) SARS-associated coronavirus transmission, United States (edit)
SARS-virus (edit) SARS-associated coronavirus transmitted from human to pig (edit)
SARS-virus (edit) SARS-associated coronavirus. (edit)
SARS-virus (edit) SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases (edit)
SARS-virus (edit) SARS-coronavirus (edit)
SARS-virus (edit) SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. (edit)
SARS-virus (edit) SARS-coronavirus replicates in mononuclear cells of peripheral blood (edit)
SARS-virus (edit) SARS-coronavirus replication in human peripheral monocytes/macrophages (edit)
SARS-virus (edit) SARS-coronavirus replication/transcription complexes are membrane-protected and need a host factor for activity in vitro. (edit)
SARS-virus (edit) SARS-coronavirus spike S2 domain flanked by cysteine residues C822 and C833 is important for activation of membrane fusion (edit)
SARS-virus (edit) SARS-like virus in the Middle East: a truly bat-related coronavirus causing human diseases (edit)
SARS-virus (edit) SARS-like virus reignites ownership feuds. (edit)
SARS-virus (edit) SARS-related virus predating SARS outbreak, Hong Kong (edit)
SARS-virus (edit) SARS: an amalgam of avian and mammalian viruses? (edit)
SARS-virus (edit) SARS: clinical virology and pathogenesis (edit)
SARS-virus (edit) SARS: just another viral acronym? (edit)
SARS-virus (edit) SARS: lessons learned from other coronaviruses. (edit)
SARS-virus (edit) SARS: responding to an unknown virus (edit)
SARS-virus (edit) SARS: understanding the coronavirus: accuracy of WHO criteria was similar in a "non-SARS" hospital in Singapore. (edit)
SARS-virus (edit) SARS: understanding the coronavirus: apoptosis may explain lymphopenia of SARS. (edit)
SARS-virus (edit) SARS: understanding the virus and development of rational therapy (edit)
SARS-virus (edit) Screening and identification of linear B-cell epitopes and entry-blocking peptide of severe acute respiratory syndrome (SARS)-associated coronavirus using synthetic overlapping peptide library. (edit)
SARS-virus (edit) Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CL protease. (edit)
SARS-virus (edit) Screening of electrophilic compounds yields an aziridinyl peptide as new active-site directed SARS-CoV main protease inhibitor. (edit)
SARS-virus (edit) Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals. (edit)
SARS-virus (edit) Selection of SARS-coronavirus-specific B cell epitopes by phage peptide library screening and evaluation of the immunological effect of epitope-based peptides on mice (edit)
SARS-virus (edit) Sensitive detection of SARS coronavirus RNA by a novel asymmetric multiplex nested RT-PCR amplification coupled with oligonucleotide microarray hybridization (edit)
SARS-virus (edit) Sensitivity of SARS/MERS CoV to interferons and other drugs based on achievable serum concentrations in humans (edit)
SARS-virus (edit) Sequential affinity purification of peroxidase tagged bispecific anti-SARS-CoV antibodies on phenylboronic acid agarose. (edit)
SARS-virus (edit) Serial analysis of the plasma concentration of SARS coronavirus RNA in pediatric patients with severe acute respiratory syndrome. (edit)
SARS-virus (edit) Seroepidemiological Study on SARS-CoV IgG Antibodies of Different Populations from Several Areas. (edit)
SARS-virus (edit) Serologic and molecular biologic methods for SARS-associated coronavirus infection, Taiwan. (edit)
SARS-virus (edit) Serological Evidence of Bat SARS-Related Coronavirus Infection in Humans, China. (edit)
SARS-virus (edit) Seroprevalence of SARS Coronavirus Among Residents Near a Hospital with a Nosocomial Outbreak. (edit)
SARS-virus (edit) Seroprevalence of SARS coronavirus antibody in household contacts. (edit)
SARS-virus (edit) Seroprevalence of antibody to severe acute respiratory syndrome (edit)
SARS-virus (edit) Severe Acute Respiratory Syndrome (SARS) and the GDP. Part I : Epidemiology, virology, pathology and general health issues. (edit)
SARS-virus (edit) Severe acute respiratory syndrome (SARS) and coronavirus testing--United States, 2003. (edit)
SARS-virus (edit) Severe acute respiratory syndrome (SARS) coronavirus-induced lung epithelial cytokines exacerbate SARS pathogenesis by modulating intrinsic functions of monocyte-derived macrophages and dendritic cells (edit)
SARS-virus (edit) Severe acute respiratory syndrome (SARS) coronavirus. (edit)
SARS-virus (edit) Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine (edit)
SARS-virus (edit) Severe acute respiratory syndrome (SARS)--paradigm of an emerging viral infection. (edit)
SARS-virus (edit) Severe acute respiratory syndrome (SARS): an old virus jumping into a new host or a new creation? (edit)
SARS-virus (edit) Severe acute respiratory syndrome (SARS): development of diagnostics and antivirals (edit)
SARS-virus (edit) Severe acute respiratory syndrome coronavirus (edit)
SARS-virus (edit) Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group (edit)
SARS-virus (edit) Simultaneous detection of SARS coronavirus and influenza A viruses using real-time polymerase chain reaction. (edit)
SARS-virus (edit) Single-dose intranasal administration with mDEF201 (edit)
SARS-virus (edit) Small interfering RNA effectively inhibits the expression of SARS coronavirus membrane gene at two novel targeting sites. (edit)
SARS-virus (edit) Solution structure of the X4 protein coded by the SARS related coronavirus reveals an immunoglobulin like fold and suggests a binding activity to integrin I domains (edit)
SARS-virus (edit) Stability and inactivation of SARS coronavirus. (edit)
SARS-virus (edit) Stem-loop 1 in the 5' UTR of the SARS coronavirus can substitute for its counterpart in mouse hepatitis virus. (edit)
SARS-virus (edit) Structural analysis of inhibition mechanisms of aurintricarboxylic acid on SARS-CoV polymerase and other proteins. (edit)
SARS-virus (edit) Structural and biochemical basis for the difference in the helicase activity of two different constructs of SARS-CoV helicase. (edit)
SARS-virus (edit) Structural and biochemical investigation of heptad repeat derived peptides of human SARS corona virus (hSARS-CoV) spike protein (edit)
SARS-virus (edit) Structural and dynamic characterization of the interaction of the putative fusion peptide of the S2 SARS-CoV virus protein with lipid membranes. (edit)
SARS-virus (edit) Structural biology. Adaptation of SARS coronavirus to humans. (edit)
SARS-virus (edit) Structural insights into SARS coronavirus proteins (edit)
SARS-virus (edit) Structural insights of a self-assembling 9-residue peptide from the C-terminal tail of the SARS corona virus E-protein in DPC and SDS micelles: A combined high and low resolution spectroscopic study. (edit)
SARS-virus (edit) Structural organization of the genome of SARS-associated coronavirus (edit)
SARS-virus (edit) Structural proteomics of the SARS coronavirus: a model response to emerging infectious diseases (edit)
SARS-virus (edit) Structure based computational assessment of channel properties of assembled ORF-8a from SARS-CoV. (edit)
SARS-virus (edit) Structure of a Conserved RNA Element in the SARS Virus Genome Determined (edit)
SARS-virus (edit) Structure of a SARS coronavirus-derived peptide bound to the human major histocompatibility complex class I molecule HLA-B*1501 (edit)
SARS-virus (edit) Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors (edit)
SARS-virus (edit) Structure-based preliminary analysis of immunity and virulence of SARS coronavirus. (edit)
SARS-virus (edit) Structure-based virtual screening against SARS-3CL (edit)
SARS-virus (edit) Studies explore impact of new pathogens: investigators report on metapneumovirus, SARS. (edit)
SARS-virus (edit) Studies of SARS virus vaccines (edit)
SARS-virus (edit) Study on interaction between SARS-CoV N and MAP19 (edit)
SARS-virus (edit) Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain. (edit)
SARS-virus (edit) Substitution at aspartic acid 1128 in the SARS coronavirus spike glycoprotein mediates escape from a S2 domain-targeting neutralizing monoclonal antibody (edit)
SARS-virus (edit) Substrate specificity and rational design of peptidomimetic inhibitors for SARS coronavirus main protease (edit)
SARS-virus (edit) Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus (edit)
SARS-virus (edit) Surface ultrastructure of SARS coronavirus revealed by atomic force microscopy. (edit)
SARS-virus (edit) Surface vimentin is critical for the cell entry of SARS-CoV. (edit)
SARS-virus (edit) Susceptibility of pigs and chickens to SARS coronavirus (edit)
SARS-virus (edit) Symptoms of infection caused by SARS coronavirus in laboratory mice and guinea pigs. (edit)
SARS-virus (edit) Synergistic inhibitor binding to the papain-like protease of human SARS coronavirus: mechanistic and inhibitor design implications (edit)
SARS-virus (edit) Synthesis and activity of an octapeptide inhibitor designed for SARS coronavirus main proteinase (edit)
SARS-virus (edit) Synthesis and antiviral evaluation of 7-O-arylmethylquercetin derivatives against SARS-associated coronavirus (edit)
SARS-virus (edit) Synthesis and biological evaluation of nucleoside analogues having 6-chloropurine as anti-SARS-CoV agents. (edit)
SARS-virus (edit) Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors. (edit)
SARS-virus (edit) Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors. (edit)
SARS-virus (edit) Synthesis of cyclopentenyl carbocyclic nucleosides as potential antiviral agents against orthopoxviruses and SARS. (edit)
SARS-virus (edit) Synthesis of novel test compounds for antiviral chemotherapy of severe acute respiratory syndrome (SARS). (edit)
SARS-virus (edit) Synthesis of stilbene derivatives with inhibition of SARS coronavirus replication. (edit)
SARS-virus (edit) Synthesis, docking studies, and evaluation of pyrimidines as inhibitors of SARS-CoV 3CL protease. (edit)
SARS-virus (edit) Synthesis, modification and docking studies of 5-sulfonyl isatin derivatives as SARS-CoV 3C-like protease inhibitors. (edit)
SARS-virus (edit) Synthetic peptides coupled to the surface of liposomes effectively induce SARS coronavirus-specific cytotoxic T lymphocytes and viral clearance in HLA-A*0201 transgenic mice (edit)
SARS-virus (edit) Synthetic peptides derived from SARS coronavirus S protein with diagnostic and therapeutic potential. (edit)
SARS-virus (edit) Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice (edit)
SARS-virus (edit) T cell responses to whole SARS coronavirus in humans (edit)
SARS-virus (edit) T-Cell response profiling to biological threat agents including the SARS coronavirus. (edit)
SARS-virus (edit) T-cell epitopes in severe acute respiratory syndrome (edit)
SARS-virus (edit) T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV. (edit)
SARS-virus (edit) TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds (edit)
SARS-virus (edit) TNF-alpha inhibition for potential therapeutic modulation of SARS coronavirus infection. (edit)
SARS-virus (edit) Tears and conjunctival scrapings for coronavirus in patients with SARS. (edit)
SARS-virus (edit) Template-based coiled-coil antigens elicit neutralizing antibodies to the SARS-coronavirus. (edit)
SARS-virus (edit) Ten years after SARS: where was the virus from? (edit)
SARS-virus (edit) Tertiary structure prediction of SARS coronavirus helicase. (edit)
SARS-virus (edit) Testing the hypothesis of a recombinant origin of the SARS-associated coronavirus. (edit)
SARS-virus (edit) The C-terminal portion of the nucleocapsid protein demonstrates SARS-CoV antigenicity (edit)
SARS-virus (edit) The Effects of Temperature and Relative Humidity on the Viability of the SARS Coronavirus. (edit)
SARS-virus (edit) The H7N9 influenza virus in China--changes since SARS. (edit)
SARS-virus (edit) The R protein of SARS-CoV: analyses of structure and function based on four complete genome sequences of isolates BJ01-BJ04. (edit)
SARS-virus (edit) The SARS coronavirus E protein interacts with PALS1 and alters tight junction formation and epithelial morphogenesis. (edit)
SARS-virus (edit) The SARS coronavirus E protein interacts with the PALS1 and alters tight junction formation and epithelial morphogenesis. (edit)
SARS-virus (edit) The SARS coronavirus nucleocapsid protein--forms and functions. (edit)
SARS-virus (edit) The SARS coronavirus: rapid diagnostics in the limelight. (edit)
SARS-virus (edit) The SARS-CoV ferret model in an infection-challenge study. (edit)
SARS-virus (edit) The SARS-CoV heptad repeat 2 exhibits pH-induced helix formation. (edit)
SARS-virus (edit) The SARS-like coronaviruses: the role of bats and evolutionary relationships with SARS coronavirus. (edit)
SARS-virus (edit) The SR-rich motif in SARS-CoV nucleocapsid protein is important for virus replication. (edit)
SARS-virus (edit) The Severe Acute Respiratory Syndrome (SARS)-coronavirus 3a protein may function as a modulator of the trafficking properties of the spike protein (edit)
SARS-virus (edit) The adamantane-derived bananins are potent inhibitors of the helicase activities and replication of SARS coronavirus. (edit)
SARS-virus (edit) The antiviral action of common household disinfectants and antiseptics against murine hepatitis virus, a potential surrogate for SARS coronavirus. (edit)
SARS-virus (edit) The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA protein. (edit)
SARS-virus (edit) The design and application of DNA chips for early detection of SARS-CoV from clinical samples. (edit)
SARS-virus (edit) The development of vaccines against SARS corona virus in mice and SCID-PBL/hu mice. (edit)
SARS-virus (edit) The dimer interface of the SARS coronavirus nucleocapsid protein adapts a porcine respiratory and reproductive syndrome virus-like structure. (edit)
SARS-virus (edit) The effect of SARS coronavirus on blood system: its clinical findings and the pathophysiologic hypothesis (edit)
SARS-virus (edit) The effect of inhibition of PP1 and TNFα signaling on pathogenesis of SARS coronavirus (edit)
SARS-virus (edit) The epitope study on the SARS-CoV nucleocapsid protein. (edit)
SARS-virus (edit) The expression of SARS-CoV M gene in P. Pastoris and the diagnostic utility of the expression product. (edit)
SARS-virus (edit) The expression of membrane protein augments the specific responses induced by SARS-CoV nucleocapsid DNA immunization. (edit)
SARS-virus (edit) The financial impact of controlling a respiratory virus outbreak in a teaching hospital: lessons learned from SARS. (edit)
SARS-virus (edit) The immune responses of HLA-A*0201 restricted SARS-CoV S peptide-specific CD8⁺ T cells are augmented in varying degrees by CpG ODN, PolyI:C and R848. (edit)
SARS-virus (edit) The immunity induced by recombinant spike proteins of SARS coronavirus in Balb/c mice. (edit)
SARS-virus (edit) The interaction of the SARS coronavirus non-structural protein 10 with the cellular oxido-reductase system causes an extensive cytopathic effect (edit)
SARS-virus (edit) The large 386-nt deletion in SARS-associated coronavirus: evidence for quasispecies? (edit)
SARS-virus (edit) The management of coronavirus infections with particular reference to SARS. (edit)
SARS-virus (edit) The newly emerged SARS-like coronavirus HCoV-EMC also has an "Achilles' heel": current effective inhibitor targeting a 3C-like protease (edit)
SARS-virus (edit) The nucleocapsid protein of SARS-CoV induces transcription of hfgl2 prothrombinase gene dependent on C/EBP alpha. (edit)
SARS-virus (edit) The nucleocapsid protein of the SARS coronavirus is capable of self-association through a C-terminal 209 amino acid interaction domain (edit)
SARS-virus (edit) The phylogeny of SARS coronavirus (edit)
SARS-virus (edit) The replication of a mouse adapted SARS-CoV in a mouse cell line stably expressing the murine SARS-CoV receptor mACE2 efficiently induces the expression of proinflammatory cytokines. (edit)
SARS-virus (edit) The role of epidermal growth factor receptor (EGFR) signaling in SARS coronavirus-induced pulmonary fibrosis (edit)
SARS-virus (edit) The role of severe acute respiratory syndrome (SARS)-coronavirus accessory proteins in virus pathogenesis (edit)
SARS-virus (edit) The route of inoculation determines the tissue tropism of modified vaccinia Tiantan expressing the spike glycoprotein of SARS-CoV in mice. (edit)
SARS-virus (edit) The secret life of ACE2 as a receptor for the SARS virus. (edit)
SARS-virus (edit) The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 (edit)
SARS-virus (edit) The spike protein of SARS-CoV--a target for vaccine and therapeutic development (edit)
SARS-virus (edit) The spike protein of severe acute respiratory syndrome (SARS) is cleaved in virus infected Vero-E6 cells (edit)
SARS-virus (edit) The structural characterization and antigenicity of the S protein of SARS-CoV. (edit)
SARS-virus (edit) The structure analysis and antigenicity study of the N protein of SARS-CoV. (edit)
SARS-virus (edit) The structure of a rigorously conserved RNA element within the SARS virus genome (edit)
SARS-virus (edit) Therapeutic options for Middle East respiratory syndrome coronavirus (MERS-CoV)--possible lessons from a systematic review of SARS-CoV therapy (edit)
SARS-virus (edit) Thermostability of the N-terminal RNA-binding domain of the SARS-CoV nucleocapsid protein: experiments and numerical simulations (edit)
SARS-virus (edit) Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS (edit)
SARS-virus (edit) Toll-like receptors, chemokine receptors and death receptor ligands responses in SARS coronavirus infected human monocyte derived dendritic cells. (edit)
SARS-virus (edit) Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication. (edit)
SARS-virus (edit) Topographic changes in SARS coronavirus-infected cells at late stages of infection (edit)
SARS-virus (edit) Towards our understanding of SARS-CoV, an emerging and devastating but quickly conquered virus (edit)
SARS-virus (edit) Tracing SARS-coronavirus variant with large genomic deletion. (edit)
SARS-virus (edit) Tracing the SARS-coronavirus (edit)
SARS-virus (edit) Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication. (edit)
SARS-virus (edit) Transient oligomerization of the SARS-CoV N protein--implication for virus ribonucleoprotein packaging. (edit)
SARS-virus (edit) Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: the possible role of dry surface contamination. (edit)
SARS-virus (edit) Travel implications of emerging coronaviruses: SARS and MERS-CoV. (edit)
SARS-virus (edit) Tryptophan-dependent membrane interaction and heteromerization with the internal fusion peptide by the membrane proximal external region of SARS-CoV spike protein. (edit)
SARS-virus (edit) Two strains of the SARS virus sequenced. (edit)
SARS-virus (edit) Two-way antigenic cross-reactivity between severe acute respiratory syndrome coronavirus (SARS-CoV) and group 1 animal CoVs is mediated through an antigenic site in the N-terminal region of the SARS-CoV nucleoprotein (edit)
SARS-virus (edit) Tyrosine dephosphorylation of STAT3 in SARS coronavirus-infected Vero E6 cells (edit)
SARS-virus (edit) Ultrastructure of SARS-CoV, FIPV, and MHV revealed by electron cryomicroscopy. (edit)
SARS-virus (edit) Understanding bat SARS-like coronaviruses for the preparation of future coronavirus outbreaks - Implications for coronavirus vaccine development (edit)
SARS-virus (edit) Understanding the T cell immune response in SARS coronavirus infection (edit)
SARS-virus (edit) Unique SARS-CoV protein nsp1: bioinformatics, biochemistry and potential effects on virulence (edit)
SARS-virus (edit) Unraveling the complexities of the interferon response during SARS-CoV infection. (edit)
SARS-virus (edit) Update on SARS research and other possibly zoonotic coronaviruses (edit)
SARS-virus (edit) Use of dual TaqMan probes to increase the sensitivity of 1-step quantitative reverse transcription-PCR: application to the detection of SARS coronavirus. (edit)
SARS-virus (edit) Using patient-collected clinical samples and sera to detect and quantify the severe acute respiratory syndrome coronavirus (edit)
SARS-virus (edit) Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque (edit)
SARS-virus (edit) Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for severe acute respiratory syndrome coronavirus (SARS-CoV) (edit)
SARS-virus (edit) Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants (edit)
SARS-virus (edit) Viral aetiology of acute respiratory illnesses in patients with a suspicion of severe acute respiratory syndrome (edit)
SARS-virus (edit) Viral evolution and the emergence of SARS coronavirus (edit)
SARS-virus (edit) Viral load and outcome in SARS infection: the role of personal protective equipment in the emergency department. (edit)
SARS-virus (edit) Viral load distribution in SARS outbreak (edit)
SARS-virus (edit) Viral load quantitation of SARS-coronavirus RNA using a one-step real-time RT-PCR. (edit)
SARS-virus (edit) Viral loads in clinical specimens and SARS manifestations. (edit)
SARS-virus (edit) Viral pathogens and acute lung injury: investigations inspired by the SARS epidemic and the 2009 H1N1 influenza pandemic (edit)
SARS-virus (edit) Virology. Researchers tie deadly SARS virus to bats. (edit)
SARS-virus (edit) Virology. The SARS coronavirus: a postgenomic era. (edit)
SARS-virus (edit) Virology: SARS virus infection of cats and ferrets. (edit)
SARS-virus (edit) Virtual screening for SARS-CoV protease based on KZ7088 pharmacophore points. (edit)
SARS-virus (edit) Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy. (edit)
SARS-virus (edit) Virtual screening of novel noncovalent inhibitors for SARS-CoV 3C-like proteinase. (edit)
SARS-virus (edit) Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses. (edit)
SARS-virus (edit) Virus Infection and Titration of SARS-CoV in Mouse Lung (edit)
SARS-virus (edit) Virus detectives seek source of SARS in China's wild animals. (edit)
SARS-virus (edit) Virus-like particles of SARS-like coronavirus formed by membrane proteins from different origins demonstrate stimulating activity in human dendritic cells (edit)
SARS-virus (edit) Virus-specific RNA and antibody from convalescent-phase SARS patients discharged from hospital (edit)
SARS-virus (edit) Vitamin C and SARS coronavirus. (edit)
SARS-virus (edit) When animal viruses attack: SARS and avian influenza. (edit)
SARS-virus (edit) Why are HIV-1 fusion inhibitors not effective against SARS-CoV? Biophysical evaluation of molecular interactions. (edit)
SARS-virus (edit) Yeast based small molecule screen for inhibitors of SARS-CoV (edit)
SARS-virus (edit) Yeast expression and characterization of SARS-CoV N protein. (edit)
SARS-virus (edit) Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate (edit)
SARS-virus (edit) ZCURVE_CoV: a new system to recognize protein coding genes in coronavirus genomes, and its applications in analyzing SARS-CoV genomes. (edit)
SARS-virus (edit) [A novel coronavirus---SARS virus]. (edit)
SARS-virus (edit) [A preliminary study of the structure prediction and expression of SARS-CoV spike protein]. (edit)
SARS-virus (edit) [A study of pulmonary inflammatory reaction induced by N-protein of SARS-CoV in rat models and effects of glucocorticoids on it]. (edit)
SARS-virus (edit) [Amplification and cloning of the N gene of SARS-associated coronavirus]. (edit)
SARS-virus (edit) [An epidemiological investigation of bats carrying SARS-CoV in Guangzhou and its vicinity]. (edit)
SARS-virus (edit) [Analysis of false-positive associated with antibody tests for SARS-CoV in SLE patients]. (edit)
SARS-virus (edit) [Analysis on the SARS-CoV genome of PUMC01 isolate]. (edit)
SARS-virus (edit) [Antigenicity characterization of six different fragments of SARS-CoV N protein expressed in E. coli]. (edit)
SARS-virus (edit) [Clinical detection of polymerase gene of SARS-associated coronavirus]. (edit)
SARS-virus (edit) [Cloning of ACE-2 gene encoding the functional receptor for the SARS coronavirus and its expression in eukaryotic cells]. (edit)
SARS-virus (edit) [Cloning, expression and purification of SARS coronavirus PUMC2 strain nucleocapsid protein]. (edit)
SARS-virus (edit) [Cloning, purification, and antigenic characterization of three recombinant fragments derived from SARS-CoV S1 domain]. (edit)
SARS-virus (edit) [Comparison of serum biochemical features between SARS and other viral pneumonias]. (edit)
SARS-virus (edit) [Conditions for SARS-CoV cultivation and inactivation]. (edit)
SARS-virus (edit) [Construction and screening of human phage antibody library against SARS virus]. (edit)
SARS-virus (edit) [Detection of SARS coronavirus RNA]. (edit)
SARS-virus (edit) [Detection of SARS-CoV RNA in stool samples of SARS patients by nest RT-PCR and its clinical value]. (edit)
SARS-virus (edit) [Detection of SARS-associated coronavirus N protein by time-resolved fluoroimmunoassay]. (edit)
SARS-virus (edit) [Detection of SARS-coronavirus in both human and animals by RT-PCR]. (edit)
SARS-virus (edit) [Detection of the anti-SARS-coronavirus specific antibody levels in 156 SARS patients]. (edit)
SARS-virus (edit) [Detection of the mRNA expression of human angiotensin-converting enzyme 2 as a SARS coronavirus functional receptor in human femoral head]. (edit)
SARS-virus (edit) [Determination of SARS-CoV by simplified nested fluorescent RT-PCR]. (edit)
SARS-virus (edit) [Development and application of a safe SARS-CoV neutralization assay based on lentiviral vectors pseudotyped with SARS-CoV spike protein]. (edit)
SARS-virus (edit) [Development of monoclonal antibodies against SARS-CoV and identification of antigenic epitopes]. (edit)
SARS-virus (edit) [Development of the cDNA chip for SARS virus and a primary study on the possible molecular mechanism of interferon alpha2b inhibiting the SARS virus replication]. (edit)
SARS-virus (edit) [Effect of SARS-associated coronavirus on peripheral blood picture and liver function]. (edit)
SARS-virus (edit) [Enhanced-real time PCR: a highly sensitive method for SARS-coronavirus detection]. (edit)
SARS-virus (edit) [Expression of SARS coronavirus nucleocapsid protein and construction of its DNA vaccine]. (edit)
SARS-virus (edit) [Expression of SARS-CoV in various types of cells in lung tissues]. (edit)
SARS-virus (edit) [Expression of predicted B cell epitope peptide in S2 subunit of SARS coronavirus spike protein in E.coli and identification of its mimic antigenicity]. (edit)
SARS-virus (edit) [Expression, purification and antibody preparation of recombinat SARS-CoV X5 protein]. (edit)
SARS-virus (edit) [Expression, purification and identification of recombinant SARS coronavirus membrane protein]. (edit)
SARS-virus (edit) [Follow up study on viruses associated with SARS among the SARS patients]. (edit)
SARS-virus (edit) [Gene prediction and function research of SARS-CoV (edit)
SARS-virus (edit) [Gene sequence analysis of SARS-associated coronavirus by nested RT-PCR]. (edit)
SARS-virus (edit) [Genetic variation analysis of SARS coronavirus]. (edit)
SARS-virus (edit) [High-efficiency expression of a receptor-binding domain of SARS-CoV spike protein in tobacco chloroplasts]. (edit)
SARS-virus (edit) [Initial analysis of complete genome sequences of SARS coronavirus]. (edit)
SARS-virus (edit) [Modeling of the SARS coronavirus main proteinase and conformational flexibility of the active site]. (edit)
SARS-virus (edit) [Modified molecular beacon-based dual real-time PCR for detection of SARS virus and its application]. (edit)
SARS-virus (edit) [Optimization of expression condition of SARS-CoV PUPs genes in E. coli]. (edit)
SARS-virus (edit) [Over-expression in Escherichia coli and purification of nucleocaspid and membrane protein of SARS coronavirus]. (edit)
SARS-virus (edit) [Preparation of specific monoclonal antibody against nucleocapsid protein of SARS coronavirus]. (edit)
SARS-virus (edit) [Prokaryotic expression of SARS coronavirus spike protein and construction of its DNA vaccine]. (edit)
SARS-virus (edit) [RNase III-prepared short interfering RNAs induce degradation of SARS-coronavirus mRNAs in human cells]. (edit)
SARS-virus (edit) [SARS coronavirus]. (edit)
SARS-virus (edit) [SARS: a new paramyxovirus or coronavirus?]. (edit)
SARS-virus (edit) [Serological analysis of SARS Coronavirus in children diagnosed clinically as severe acute respiratory syndrome cases during SARS epidemic in Beijing]. (edit)
SARS-virus (edit) [Some medical staff positive for serum SARS coronavirus antibody IgG have only mild symptoms]. (edit)
SARS-virus (edit) [Study on the RNA of severe acute respiratory syndrome (edit)
SARS-virus (edit) [Study on the changing regularity of special antibody and expression of stomach and enteric involvement on SARS-coronavirus infection in the recovery period of severe acute respiratory syndrome]. (edit)
SARS-virus (edit) [The biological characteristics of SARS virus and its related coronaviruses]. (edit)
SARS-virus (edit) [The cloning, expression, purification and identification of SARS virus S2 gene and study on its immunological characteristics]. (edit)
SARS-virus (edit) [The expression and activity detection of a variant N protein of SARS-CoV]. (edit)
SARS-virus (edit) [The genome comparison of SARS-CoV and other coronaviruses]. (edit)
SARS-virus (edit) [Variability analysis of S2 gene of SARS-CoV]. (edit)
SARS-virus (edit) [cDNAs cloning of SARS-CoV PUMC2 viral genome]. (edit)
SARS-virus (edit) siRNA targeting the leader sequence of SARS-CoV inhibits virus replication. (edit)

Broncode voorbeelden

curl

curl -s https://raw.githubusercontent.com/egonw/SARS-CoV-2-Queries/master/sparql/compareViruses.rq | sed 's+<lang/>+nl+' > compareViruses.rq

curl -H "Accept: text/tab-separated-values" -G https://query.wikidata.org/bigdata/namespace/wdq/sparql --data-urlencode query@compareViruses.rq

Deze SPARQL zoekopdracht is beschikbaar als CCZero